Australian Broker Call
Produced and copyrighted by
at www.fnarena.com
August 18, 2026
Access Broker Call Report Archives here
COMPANIES DISCUSSED IN THIS ISSUE
Click on symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1).
Last Updated: 05:00 PM
Your daily news report on the latest recommendation, valuation, forecast and opinion changes.
This report includes concise but limited reviews of research recently published by Stockbrokers, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end.
For more info about the different terms used by stockbrokers, as well as the different methodologies behind similar sounding ratings, download our guide HERE
Today's Upgrades and Downgrades
| A2M - | a2 Milk Co | Upgrade to Buy from Neutral | Citi |
| AD8 - | Audinate Group | Upgrade to Outperform from Neutral | Macquarie |
| Upgrade to Overweight from Equal-weight | Morgan Stanley | ||
| ALL - | Aristocrat Leisure | Downgrade to Accumulate from Buy | Morgans |
| AZJ - | Aurizon Holdings | Upgrade to Hold from Trim | Morgans |
| BSL - | BlueScope Steel | Downgrade to Lighten from Hold | Ord Minnett |
| EDV - | Endeavour Group | Downgrade to Hold from Buy | Bell Potter |
| FRW - | Freightways Group | Downgrade to Accumulate from Buy | Ord Minnett |
| GPT - | GPT Group | Downgrade to Neutral from Outperform | Macquarie |
| IMD - | Imdex | Downgrade to Hold from Buy | Bell Potter |
| Downgrade to Accumulate from Buy | Morgans | ||
| NST - | Northern Star Resources | Downgrade to Neutral from Buy | Citi |
Overnight Price: $6.53
Bell Potter rates A2M as Hold (3) -
Bell Potter maintains a Hold rating for a2 Milk Co with its target price increased to $7.00 from $6.90 following FY26 results aligning broadly with forecasts.
Group revenue expanded 4% to NZ$1.97bn, supporting a 4% increase in EBITDA to NZ$284.4m and a 2% uplift in underlying net profit after tax to NZ$207.5m.
The analyst notes management expects FY27 supply chain losses from the Pokeno facility to improve materially to breakeven, offsetting a guided near-term margin contraction in the first half.
The broker's estimates incorporate -2% and -1% reductions to FY27 and FY28 net profit forecasts respectively, reflecting softer near-term earnings expectations balanced against a stronger net cash position of NZ$760.2m.
Commentary suggests achieving current valuations relies heavily on recovering and expanding market share within China, with recent supply chain disruptions shifting growth timelines further into the future.
Target price is $7.00 Current Price is $6.53 Difference: $0.47
If A2M meets the Bell Potter target it will return approximately 7% (excluding dividends, fees and charges).
Current consensus price target is $7.80, suggesting upside of 10.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Bell Potter forecasts a full year FY27 dividend of 19.56 cents and EPS of 25.25 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 24.7, implying annual growth of N/A. Current consensus DPS estimate is 17.9, implying a prospective dividend yield of 2.5%. Current consensus EPS estimate suggests the PER is 28.7. |
Forecast for FY28:
Bell Potter forecasts a full year FY28 dividend of 23.38 cents and EPS of 30.61 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 31.1, implying annual growth of 25.9%. Current consensus DPS estimate is 23.1, implying a prospective dividend yield of 3.3%. Current consensus EPS estimate suggests the PER is 22.8. |
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Citi rates A2M as Upgrade to Buy from Neutral (1) -
Citi upgrades a2 Milk to Buy from Neutral, confident management can recover market share lost during recent supply chain disruptions faster than previously anticipated.
The company's strong execution track record underpins the more positive view, although the recovery is still expected to take time. Investors are likely to remain patient provided offtake and other operating metrics continue to improve.
The China label recovery results will be more significant than FY27 guidance, with the analyst believing management has de-risked the operational supply problem, now it is about whether it can recover enough to justify FY28 earnings.
The November 2026 AGM is identified as the next key catalyst. Target price is raised to $7.40.
First take: Citi views a2 Milk Co's FY26 as basically meeting expectations with net profit after tax of NZ$207.5m, slightly above consensus expectations.
Management offered a guidance update on 7 July. Disruption to the supply chain for China label has come in worse than historical market share data has inferred.
Positively, the broker points out the Pokeno transformation is doing well and is less of an earnings drag and more of a margin tailwind.
FY27 maiden guidance has come in about -8% below consensus at the mid-point resulting from the supply chain challenges and disruptions in 4Q26.
Citi analysts emphasise they have been flagging this risk for a while.
Target $7. Neutral rated.
Target price is $7.40 Current Price is $6.53 Difference: $0.87
If A2M meets the Citi target it will return approximately 13% (excluding dividends, fees and charges).
Current consensus price target is $7.80, suggesting upside of 10.1% (ex-dividends)
Forecast for FY27:
Current consensus EPS estimate is 24.7, implying annual growth of N/A. Current consensus DPS estimate is 17.9, implying a prospective dividend yield of 2.5%. Current consensus EPS estimate suggests the PER is 28.7. |
Forecast for FY28:
Current consensus EPS estimate is 31.1, implying annual growth of 25.9%. Current consensus DPS estimate is 23.1, implying a prospective dividend yield of 3.3%. Current consensus EPS estimate suggests the PER is 22.8. |
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Macquarie rates A2M as Outperform (1) -
a2 Milk Co's FY26 saw 12% sales growth despite supply issues and earnings up 8%. June Q China label share was weak due to supply, but the rebuild is progressing, Macquarie notes.
FY27 sales guidance for 4%-6% growth appears conservative to the broker, as does a 15% earnings margin outlook given reinvestment in marketing.
Commentary highlights growth outside of infant formula has been strong, with more to come.
Macquarie maintains Outperform with conservative FY27 guidance likely the turning point for news flow as recovery certainty improves, backed by strong brand, trade support and track record of execution. On a 25x PER, this is the lower end of historic range.
Target falls to $8.10 from $8.50.
Target price is $8.10 Current Price is $6.53 Difference: $1.57
If A2M meets the Macquarie target it will return approximately 24% (excluding dividends, fees and charges).
Current consensus price target is $7.80, suggesting upside of 10.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Macquarie forecasts a full year FY27 dividend of 20.58 cents and EPS of 26.36 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 24.7, implying annual growth of N/A. Current consensus DPS estimate is 17.9, implying a prospective dividend yield of 2.5%. Current consensus EPS estimate suggests the PER is 28.7. |
Forecast for FY28:
Macquarie forecasts a full year FY28 dividend of 27.80 cents and EPS of 34.69 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 31.1, implying annual growth of 25.9%. Current consensus DPS estimate is 23.1, implying a prospective dividend yield of 3.3%. Current consensus EPS estimate suggests the PER is 22.8. |
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Morgans rates A2M as Accumulate (2) -
a2 Milk Co's FY26 result is broadly in line with Morgans's expectations. FY27 guidance is materially weaker than expected though likely conservative, the analyst suggests.
Commentary notes China-label infant formula sales fell -14% due to supply and freight disruptions, while English-label infant formula and liquid milk delivered strong growth.
The broker expects a weak first half before double-digit profit growth resumes from 2H27, supported by new products, supply-chain improvements and geographic expansion.
Morgans lowers its FY27-FY29 earnings forecasts by -8.6%, -4.3% and -4.1%, respectively, but expects guidance could be upgraded. The target is lowered to $7.62 from $8.30. Accumulate rating retained.
Target price is $7.62 Current Price is $6.53 Difference: $1.09
If A2M meets the Morgans target it will return approximately 17% (excluding dividends, fees and charges).
Current consensus price target is $7.80, suggesting upside of 10.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Morgans forecasts a full year FY27 dividend of 18.71 cents and EPS of 25.51 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 24.7, implying annual growth of N/A. Current consensus DPS estimate is 17.9, implying a prospective dividend yield of 2.5%. Current consensus EPS estimate suggests the PER is 28.7. |
Forecast for FY28:
Morgans forecasts a full year FY28 dividend of 22.96 cents and EPS of 31.46 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 31.1, implying annual growth of 25.9%. Current consensus DPS estimate is 23.1, implying a prospective dividend yield of 3.3%. Current consensus EPS estimate suggests the PER is 22.8. |
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Ord Minnett rates A2M as Buy (1) -
a2 Milk Company's FY26 result was broadly in line with the guidance provided in July, with revenue rising 12.4% year on year, 1.0% ahead of consensus. Reported profit fell -5.8% but was ahead of consensus by 1.8%.
It was a tough year, Ord Minnett notes, with a product recall in the US, and supply chain disruptions in China-label infant milk formula. Nevertheless, the business was able to grow sales. Revenue increased across all regions.
Guidance for FY27 underwhelmed, the broker notes, suggesting mid-single-digit revenue growth and an earnings margin of around 15%, with the first half FY27 margin materially down on first-half FY26.
While the 15% margin is a recovery from the shortage-affected FY26 margin of 14.4%, the recovery is not as swift as Ord Minnett hoped.
The broker maintains Buy, seeing the issues that have impacted on earnings as largely in the rear-view mirror, and anticipating the company can return to double-digit earnings growth in FY28 and FY29, helped too by the Pokeno acquisition.
Target falls to NZ$7.50 from NZ$9.20.
Current Price is $6.53. Target price not assessed.
Current consensus price target is $7.80, suggesting upside of 10.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Ord Minnett forecasts a full year FY27 dividend of 15.31 cents and EPS of 21.26 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 24.7, implying annual growth of N/A. Current consensus DPS estimate is 17.9, implying a prospective dividend yield of 2.5%. Current consensus EPS estimate suggests the PER is 28.7. |
Forecast for FY28:
Ord Minnett forecasts a full year FY28 dividend of 18.71 cents and EPS of 27.21 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 31.1, implying annual growth of 25.9%. Current consensus DPS estimate is 23.1, implying a prospective dividend yield of 3.3%. Current consensus EPS estimate suggests the PER is 22.8. |
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
UBS rates A2M as Buy (1) -
UBS believes the stock's de-rating is overdone while acknowledging some question marks remain around the China supply issues and the US product recall.
The analyst views the possibility of further ARA-related infant formula issues as low. Even with the "conservative" earnings assumptions around China label customer losses, forecast net profit after tax is still expected to double by FY31, with market share gains.
The stock is trading well below its long-term valuation of 32x. Buy rated with a NZ$9.20 target price.
EPS forecasts slip by -5% for FY27 and lift by 2% for FY28.
First Take: UBS notes a2 Milk Co's FY26 earnings were broadly in line with expectations and consensus, with revenue up 3.8% to NZ$1.98bn and normalised EBITDA up 3.8% to NZ$284m.
Infant formula sales rose 5%, liquid milk sales increased 17% and other nutritionals sales jumped 60%, while the EBITDA margin was steady at 14.4%.
FY27 guidance disappointed, with mid-single-digit revenue growth and a circa 15% EBITDA margin, leaving EBITDA around -7% to -9% below UBS and consensus forecasts.
Infant formula sales are expected to be broadly flat in FY27, compared with forecasts for 9% growth, while increased marketing and reduced operating leverage will weigh on margins.
Buy. Target NZ$9.20.
Current Price is $6.53. Target price not assessed.
Current consensus price target is $7.80, suggesting upside of 10.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
UBS forecasts a full year FY27 dividend of 17.86 cents and EPS of 26.36 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 24.7, implying annual growth of N/A. Current consensus DPS estimate is 17.9, implying a prospective dividend yield of 2.5%. Current consensus EPS estimate suggests the PER is 28.7. |
Forecast for FY28:
UBS forecasts a full year FY28 dividend of 25.51 cents and EPS of 35.71 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 31.1, implying annual growth of 25.9%. Current consensus DPS estimate is 23.1, implying a prospective dividend yield of 3.3%. Current consensus EPS estimate suggests the PER is 22.8. |
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
ACL AUSTRALIAN CLINICAL LABS LIMITED
Healthcare services
More Research Tools In Stock Analysis - click HERE
Overnight Price: $2.70
Macquarie rates ACL as Neutral (3) -
Australian Clinical Labs' FY26 result surprised positively, with earnings (EBIT) 7% ahead of Macquarie's expectations due to better-than-expected margins and cost efficiencies.
Revenue fell -0.7% year-on-year, but labour and procurement efficiencies helped the EBIT margin expand by 20bps, the analyst highlights.
Commentary notes FY27 EBIT guidance of $67m-$73m is 3% above the consensus estimate at the midpoint, despite significant wage inflation pressures.
The broker expects billing initiatives, price increases, automation and AI efficiencies to help offset higher labour costs but sees execution risk. FY27-FY29 EPS forecasts are adjusted by 2%, 1% and 0%, respectively.
Macquarie raises its target to $2.70 from $2.30 and retains a Neutral rating given execution risk across initiatives to offset wage inflation.
Target price is $2.70 Current Price is $2.70 Difference: $0
If ACL meets the Macquarie target it will return approximately 0% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY27:
Macquarie forecasts a full year FY27 dividend of 17.00 cents and EPS of 19.20 cents. |
Forecast for FY28:
Macquarie forecasts a full year FY28 dividend of 19.00 cents and EPS of 20.40 cents. |
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Ord Minnett rates ACL as Hold (3) -
Australian Clinical Labs delivered a solid FY26 result in tough operating conditions, Ord Minnett suggests, with underlying profit up 4% year on year and 9% ahead of the broker.
Management continues to focus on operational efficiency, delivering 20bps of earnings margin expansion despite sluggish volumes, fee cuts and labour cost pressures.
While the pathology sector isn’t out of the woods yet, the company offers investors a best-in-class operating model and consistent execution, Ord Minnett suggests.
FY27 guidance is underpinned by billing and opex initiatives aimed at offsetting headwinds and inflationary pressures. Target rises to $2.60 from $2.20, Hold retained.
Target price is $2.60 Current Price is $2.70 Difference: minus $0.1 (current price is over target).
If ACL meets the Ord Minnett target it will return approximately minus 4% (excluding dividends, fees and charges - negative figures indicate an expected loss).
The company's fiscal year ends in June.
Forecast for FY27:
Ord Minnett forecasts a full year FY27 dividend of 13.20 cents and EPS of 18.10 cents. |
Forecast for FY28:
Ord Minnett forecasts a full year FY28 dividend of 14.40 cents and EPS of 19.80 cents. |
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $2.33
Macquarie rates AD8 as Upgrade to Outperform from Neutral (1) -
Macquarie believes Audinate Group's FY26 result marks a recovery from the post-covid downturn, with destocking complete and its core audio business stabilising.
Chips, cards and modules (CCM) growth is seen as the main source of upside, while continued AVIO Install volume growth and a shift towards higher-margin software is also expected to support earnings.
Macquarie notes restructuring benefits, including a circa -10% headcount reduction, should fully flow through in FY27, helping contain cash burn.
FY27-FY30 EPS forecasts are adjusted by -2%, 28%, 42% and 79%, respectively. The broker raises its target to $4.80 from $3.20 and upgrades to Outperform from Neutral.
Target price is $4.80 Current Price is $2.33 Difference: $2.47
If AD8 meets the Macquarie target it will return approximately 106% (excluding dividends, fees and charges).
Current consensus price target is $4.35, suggesting upside of 77.6% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Macquarie forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 21.50 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is -16.4, implying annual growth of N/A. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is N/A. |
Forecast for FY28:
Macquarie forecasts a full year FY28 dividend of 0.00 cents and EPS of minus 15.20 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is -11.9, implying annual growth of N/A. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is N/A. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Morgan Stanley rates AD8 as Upgrade to Overweight from Equal-weight (1) -
Morgan Stanley upgrades its rating for Audinate Group to Overweight with an In-Line industry view and a $3.00 target price following FY26 results that confirmed top-line growth stabilisation and inventory destocking behind it.
The analyst highlights greater cost control underpinning an improved free cash flow trajectory, bringing neutrality into view by exiting 2H27.
The broker's estimates project mid-teens gross profit growth supported by software adoption and expanding operating leverage.
Management notes solid competitive positioning across Dante audio products alongside growing video and software optionality.
The analyst views previous cyclical headwinds as largely resolved, offering an attractive risk-reward entry point.
Target price is $3.00 Current Price is $2.33 Difference: $0.67
If AD8 meets the Morgan Stanley target it will return approximately 29% (excluding dividends, fees and charges).
Current consensus price target is $4.35, suggesting upside of 77.6% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Morgan Stanley forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 13.80 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is -16.4, implying annual growth of N/A. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is N/A. |
Forecast for FY28:
Morgan Stanley forecasts a full year FY28 dividend of 0.00 cents and EPS of minus 9.50 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is -11.9, implying annual growth of N/A. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is N/A. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
UBS rates AD8 as Buy (1) -
Audinate's FY26 result was stronger than UBS expected, with gross profit rising 15% to US$38m and growth accelerating to 17% in 2H, supported by strong demand for Avio adaptors.
The analyst expects the company to return to positive EBITDA in FY27, supported by new product launches, audio price increases and tighter cost control, while subdued corporate and education markets and a slower Iris rollout remain risks.
FY27 EBITDA forecast is upgraded to $3.1m from a -$1.1m loss and FY29 EBITDA forecasts rise 56% to $15.2m, with positive free cash flow forecast in FY29 and potential for this to occur in 2H FY28.
UBS lowers its longer-term assumptions and raises WACC to 9.2% from 9.0%, despite the improved near-term earnings outlook.
The target falls to $5.25 from $6.10 and the Buy rating is retained.
Target price is $5.25 Current Price is $2.33 Difference: $2.92
If AD8 meets the UBS target it will return approximately 125% (excluding dividends, fees and charges).
Current consensus price target is $4.35, suggesting upside of 77.6% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
UBS forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 14.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is -16.4, implying annual growth of N/A. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is N/A. |
Forecast for FY28:
UBS forecasts a full year FY28 dividend of 0.00 cents and EPS of minus 11.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is -11.9, implying annual growth of N/A. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is N/A. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $64.50
Morgans rates ALL as Downgrade to Accumulate from Buy (2) -
Morgans remains positive on Aristocrat Leisure's land-based gaming momentum following the Australasian Gaming Expo, highlighting a deep product pipeline and strong demand.
Australian momentum remains solid, while North American gaming operations net additions are tracking towards the upper end of FY26 guidance, the analyst highlights.
Progress in Interactive is also noted, supported by new launches and expansion across North America, with the US$1bn FY29 revenue target reaffirmed.
Stronger land-based gaming assumptions lift FY26-FY27 EPS forecasts by around 1%. Morgans raises its target to $70.00 from $67.00 and, following recent share price strength, downgrades to Accumulate from Buy.
Target price is $70.00 Current Price is $64.50 Difference: $5.5
If ALL meets the Morgans target it will return approximately 9% (excluding dividends, fees and charges).
Current consensus price target is $65.04, suggesting upside of 2.3% (ex-dividends)
The company's fiscal year ends in September.
Forecast for FY26:
Morgans forecasts a full year FY26 dividend of 103.00 cents and EPS of 246.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 256.1, implying annual growth of 11.7%. Current consensus DPS estimate is 99.1, implying a prospective dividend yield of 1.6%. Current consensus EPS estimate suggests the PER is 24.8. |
Forecast for FY27:
Morgans forecasts a full year FY27 dividend of 114.00 cents and EPS of 282.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 287.0, implying annual growth of 12.1%. Current consensus DPS estimate is 109.8, implying a prospective dividend yield of 1.7%. Current consensus EPS estimate suggests the PER is 22.2. |
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $37.88
Citi rates ANZ as Buy (1) -
Citi remains more positive on banks with greater business lending exposure following a mixed June quarter reporting season for the majors.
Core earnings rose around 4% QoQ, although investor reactions varied considerably, with ANZ Bank standing out positively.
Looking into FY27, strong business credit demand is expected to contrast with increasing pressure on retail banking from softer mortgage volumes, deposit mix, competition and pricing, weighing on NIMs.
The broker sees fewer avenues for revenue growth as these pressures build.
EPS forecasts are tweaked and the Buy rating is retained with an unchanged target of $39.25.
Target price is $39.25 Current Price is $37.88 Difference: $1.37
If ANZ meets the Citi target it will return approximately 4% (excluding dividends, fees and charges).
Current consensus price target is $35.63, suggesting downside of -5.3% (ex-dividends)
The company's fiscal year ends in September.
Forecast for FY26:
Citi forecasts a full year FY26 dividend of 166.00 cents and EPS of 247.60 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 247.3, implying annual growth of 24.8%. Current consensus DPS estimate is 166.7, implying a prospective dividend yield of 4.4%. Current consensus EPS estimate suggests the PER is 15.2. |
Forecast for FY27:
Citi forecasts a full year FY27 dividend of 175.00 cents and EPS of 254.70 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 251.9, implying annual growth of 1.9%. Current consensus DPS estimate is 170.5, implying a prospective dividend yield of 4.5%. Current consensus EPS estimate suggests the PER is 14.9. |
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
AZJ AURIZON HOLDINGS LIMITED
Transportation & Logistics
More Research Tools In Stock Analysis - click HERE
Overnight Price: $3.73
Citi rates AZJ as Neutral (3) -
Overall, Citi views the result as "reasonable" albeit the decline in FY27 contracted tonnes outweighs the FY26 outcome. Coal risks remain high, even though network is viewed as resilient and bulk is indicating signs of improvement.
Target price is lowered to $3.90 from $4. No change to Neutral rating.
First Take: Aurizon Holdings' FY26 EBITDA of $1.724bn was in line with consensus, with Coal, Bulk and Network earnings broadly meeting expectations, Citi notes.
FY27 EBITDA guidance of $1.725bn-$1.775bn was -1% to -4% below consensus, while dividend guidance of 23c-24cps was -5% to -9% below expectations, the analyst highlights.
The outlook on Coal is considered subdued, with contracted volumes expected to fall around -9% and segment EBITDA guided lower year on year.
The broker estimates dividend guidance implies FY27 EPS could be high-single to low-double digits below consensus.
Neutral. Target $4.
Target price is $3.90 Current Price is $3.73 Difference: $0.17
If AZJ meets the Citi target it will return approximately 5% (excluding dividends, fees and charges).
Current consensus price target is $3.60, suggesting downside of -0.8% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Current consensus EPS estimate is 26.8, implying annual growth of N/A. Current consensus DPS estimate is 23.8, implying a prospective dividend yield of 6.6%. Current consensus EPS estimate suggests the PER is 13.5. |
Forecast for FY28:
Current consensus EPS estimate is 25.0, implying annual growth of -6.7%. Current consensus DPS estimate is 22.5, implying a prospective dividend yield of 6.2%. Current consensus EPS estimate suggests the PER is 14.5. |
Market Sentiment: -0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Macquarie rates AZJ as Neutral (3) -
Following further reflection upon Aurizon Holdings' FY26 results, Macquarie's FY27-FY28 EPS forecasts fall -13.5% and -10.3%, respectively.
The broker's target falls to $3.84 from $4.09 and a Neutral rating is retained.
First Take: Aurizon Holdings' FY26 EBITDA of $1.724bn was broadly in line with Macquarie and consensus, while NPAT of $433m was slightly below the broker's forecast.
FY27 EBITDA guidance of $1.725bn-$1.775bn disappointed, largely reflecting a -$60m to -$70m decline in Coal earnings following the loss of -20Mt of contracted volumes.
Macquarie notes the company has been unable to replace lost Coal volumes, while growth from Bulk and containerised freight remains insufficient to offset the weakness.
DPS guidance of 23c-24cps was also below expectations.
The analyst views Aurizon as operating in a low-growth environment with its share of the Coal market shrinking.
Target price is $3.84 Current Price is $3.73 Difference: $0.11
If AZJ meets the Macquarie target it will return approximately 3% (excluding dividends, fees and charges).
Current consensus price target is $3.60, suggesting downside of -0.8% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Macquarie forecasts a full year FY27 dividend of 23.10 cents and EPS of 25.80 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 26.8, implying annual growth of N/A. Current consensus DPS estimate is 23.8, implying a prospective dividend yield of 6.6%. Current consensus EPS estimate suggests the PER is 13.5. |
Forecast for FY28:
Macquarie forecasts a full year FY28 dividend of 22.10 cents and EPS of 24.80 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 25.0, implying annual growth of -6.7%. Current consensus DPS estimate is 22.5, implying a prospective dividend yield of 6.2%. Current consensus EPS estimate suggests the PER is 14.5. |
Market Sentiment: -0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Morgans rates AZJ as Upgrade to Hold from Trim (3) -
Morgans views Aurizon Holdings' second-half FY26 performance as solid, but FY27 earnings and dividend guidance disappointed against market expectations.
Following a material share price decline in reaction to the results, the analyst upgrades the rating to Hold from Trim with a $3.56 target, up from $3.55.
Network is seen as the key earnings driver, while Coal faces heightened recontracting risk after contracted capacity fell by -20mt to 211mtpa.
The broker expects Containerised Freight to improve from a circa -$40m earnings (EBITDA) loss in FY26 to breakeven in FY27, though this requires materially higher volumes and lower costs.
Target price is $3.56 Current Price is $3.73 Difference: minus $0.17 (current price is over target).
If AZJ meets the Morgans target it will return approximately minus 5% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $3.60, suggesting downside of -0.8% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Morgans forecasts a full year FY27 dividend of 24.00 cents and EPS of 27.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 26.8, implying annual growth of N/A. Current consensus DPS estimate is 23.8, implying a prospective dividend yield of 6.6%. Current consensus EPS estimate suggests the PER is 13.5. |
Forecast for FY28:
Morgans forecasts a full year FY28 dividend of 21.00 cents and EPS of 24.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 25.0, implying annual growth of -6.7%. Current consensus DPS estimate is 22.5, implying a prospective dividend yield of 6.2%. Current consensus EPS estimate suggests the PER is 14.5. |
Market Sentiment: -0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Ord Minnett rates AZJ as Hold (3) -
Aurizon Holdings' FY26 revenues grew 6% year on year, 1% ahead of consensus, while earnings rose 9%, meeting consensus estimates. Including the final dividend of 10.5c, 90% franked, FY26 dividends totalling 23.0x are up 46.6% year on year.
FY27 earnings guidance is slightly below consensus. Ord Minnett notes. FY27 earnings in the coal segment are expected to decline given the lower contracted coal volumes. No dividend growth is expected in FY27.
The bulk and network segments are expected to deliver earnings growth on FY26, with bulk benefiting from a higher contribution from the BHP Group ((BHP)) contract and higher grain volumes.
Ord Minnett maintains Hold and would like to see more clarity around coal contract renewals over the next 12 months to turn more positive, though the broker notes that even assuming a flat dividend in FY27, Aurizon is trading on an attractive dividend yield of circa 6%.
Target falls to $3.40 from $3.50.
Target price is $3.40 Current Price is $3.73 Difference: minus $0.33 (current price is over target).
If AZJ meets the Ord Minnett target it will return approximately minus 9% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $3.60, suggesting downside of -0.8% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Ord Minnett forecasts a full year FY27 dividend of 23.00 cents and EPS of 25.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 26.8, implying annual growth of N/A. Current consensus DPS estimate is 23.8, implying a prospective dividend yield of 6.6%. Current consensus EPS estimate suggests the PER is 13.5. |
Forecast for FY28:
Ord Minnett forecasts a full year FY28 dividend of 23.00 cents and EPS of 26.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 25.0, implying annual growth of -6.7%. Current consensus DPS estimate is 22.5, implying a prospective dividend yield of 6.2%. Current consensus EPS estimate suggests the PER is 14.5. |
Market Sentiment: -0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
UBS rates AZJ as Sell (5) -
Aurizon Holdings' FY26 underlying EBITDA of $1.72bn was in line with UBS forecasts, with stronger Network earnings offset by modest misses across the above-rail businesses.
FY27 guidance disappointed, with EBITDA of $1.73bn–$1.78bn implying only 0%–3% growth, while dividends of 23c–24cps are below prior expectations and no buyback extension was announced.
The analyst highlights lower contracted coal volumes as the key earnings headwind, with the loss of high-margin take-or-pay income worth an estimated -$60 to -$70m, while around 75mt remains to be recontracted across FY27–FY28.
New Whitehaven Coal ((WHC)) and BMA contracts provide some relief, but the broker sees ongoing recontracting risks and expects dividend growth of only around 1% pa over the next three years.
UBS lowers its target to $3.40 from $3.50 and retains a Sell rating. Dalrymple Bay Infrastructure ((DBI)) and Transurban ((TCL)) are preferred infrastructure exposures.
Target price is $3.40 Current Price is $3.73 Difference: minus $0.33 (current price is over target).
If AZJ meets the UBS target it will return approximately minus 9% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $3.60, suggesting downside of -0.8% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
UBS forecasts a full year FY27 dividend of 23.00 cents and EPS of 27.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 26.8, implying annual growth of N/A. Current consensus DPS estimate is 23.8, implying a prospective dividend yield of 6.6%. Current consensus EPS estimate suggests the PER is 13.5. |
Forecast for FY28:
UBS forecasts a full year FY28 dividend of 24.00 cents and EPS of 25.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 25.0, implying annual growth of -6.7%. Current consensus DPS estimate is 22.5, implying a prospective dividend yield of 6.2%. Current consensus EPS estimate suggests the PER is 14.5. |
Market Sentiment: -0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $62.20
Macquarie rates BHP as Neutral (3) -
First take:
It is Macquarie's initial assessment that BHP Group's FY26 performance beat on net profit by some 4%. Revenues and EBITDA are in line.
The H2 dividend of US99c is well above forecasts. Cost guidance for FY27 is deemed as in line.
The broker highlights BHP is now paying out 72% of underlying earnings in the form of dividends for shareholders.
Neutral. Target $55.
Target price is $55.00 Current Price is $62.20 Difference: minus $7.2 (current price is over target).
If BHP meets the Macquarie target it will return approximately minus 12% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $60.80, suggesting downside of -4.8% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY26:
Macquarie forecasts a full year FY26 dividend of 233.44 cents and EPS of 360.37 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 356.1, implying annual growth of N/A. Current consensus DPS estimate is 224.9, implying a prospective dividend yield of 3.5%. Current consensus EPS estimate suggests the PER is 17.9. |
Forecast for FY27:
Macquarie forecasts a full year FY27 dividend of 204.26 cents and EPS of 340.53 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 367.8, implying annual growth of 3.3%. Current consensus DPS estimate is 201.2, implying a prospective dividend yield of 3.2%. Current consensus EPS estimate suggests the PER is 17.4. |
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $32.94
Morgan Stanley rates BSL as Equal-weight (3) -
Morgan Stanley retains an Equal-weight rating and an In-Line industry view for BlueScope Steel with its target price increased to $34.00 from $32.35 following strong FY26 results and upbeat 1H27 EBIT guidance.
Underlying EBIT reached $1.27bn, exceeding consensus estimates by 2% and driven by robust performance across North Star.
The analyst highlights that 1H27 EBIT guidance of $860m to $960m sits 11% above consensus expectations at the midpoint, supported by elevated US steel spreads and additional net cost-out benefits of $150m projected for FY27.
The broker's estimates project FY27 and FY28 EBIT growth of 30.5% and 3.0% respectively, underpinned by lower capital expenditure and strong cash generation.
Management plans shareholder returns of $3.00 per share in 2027, combining ordinary dividends with buy-backs and special dividends.
Target price is $34.00 Current Price is $32.94 Difference: $1.06
If BSL meets the Morgan Stanley target it will return approximately 3% (excluding dividends, fees and charges).
Current consensus price target is $34.11, suggesting upside of 8.3% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Morgan Stanley forecasts a full year FY27 dividend of 300.00 cents and EPS of 258.40 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 240.7, implying annual growth of N/A. Current consensus DPS estimate is 172.5, implying a prospective dividend yield of 5.5%. Current consensus EPS estimate suggests the PER is 13.1. |
Forecast for FY28:
Morgan Stanley forecasts a full year FY28 dividend of 140.00 cents and EPS of 257.60 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 234.8, implying annual growth of -2.5%. Current consensus DPS estimate is 135.0, implying a prospective dividend yield of 4.3%. Current consensus EPS estimate suggests the PER is 13.4. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Ord Minnett rates BSL as Downgrade to Lighten from Hold (4) -
BlueScope Steel delivered FY26 underlying earnings of almost $1.3bn, up from $535m in FY25. Earnings in the second half were $716m, above the $620m–$700m guidance range, and 3% ahead of consensus.
FY26 earnings were largely driven by North Star, Ord Minnett notes, as steel spreads strengthened and capacity utilisation reached 100%.
In contrast, Australian earnings fell –28% due to low Asian steel spreads and higher raw material costs, even though volumes were strong.
First-half FY27 guidance is for earnings to be between $860m–$960m, significantly above consensus of $812m and the $558m a year ago.
Ord Minnett lowers its rating to Lighten from Hold, as the broker thinks a lot of good news is now factored in.
Target unchanged at $29.
Target price is $29.00 Current Price is $32.94 Difference: minus $3.94 (current price is over target).
If BSL meets the Ord Minnett target it will return approximately minus 12% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $34.11, suggesting upside of 8.3% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Ord Minnett forecasts a full year FY27 dividend of 130.00 cents and EPS of 236.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 240.7, implying annual growth of N/A. Current consensus DPS estimate is 172.5, implying a prospective dividend yield of 5.5%. Current consensus EPS estimate suggests the PER is 13.1. |
Forecast for FY28:
Ord Minnett forecasts a full year FY28 dividend of 130.00 cents and EPS of 212.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 234.8, implying annual growth of -2.5%. Current consensus DPS estimate is 135.0, implying a prospective dividend yield of 4.3%. Current consensus EPS estimate suggests the PER is 13.4. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $131.25
UBS rates COH as Neutral (3) -
First take:
UBS's first impression is that Cochlear's FY26 release is better-than-expected, helped by cost cutting and FX gains. Management's guidance for FY27 is considered in line with consensus.
Commentary explains the outlook suggests only modest sales growth in both developed and emerging markets as current trading conditions remain mixed.
Management's guidance for flat gross margins is due to the ASP headwind in China but will be offset by a reduction in operating expenditure, the broker explains.
Overall, UBS thinks today's result will likely be "good enough" given expectations for FY27 were low.
Neutral rating and $106 target.
Target price is $106.00 Current Price is $131.25 Difference: minus $25.25 (current price is over target).
If COH meets the UBS target it will return approximately minus 19% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $114.03, suggesting downside of -19.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY26:
UBS forecasts a full year FY26 dividend of 325.00 cents and EPS of 463.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 459.8, implying annual growth of -22.6%. Current consensus DPS estimate is 323.5, implying a prospective dividend yield of 2.3%. Current consensus EPS estimate suggests the PER is 30.7. |
Forecast for FY27:
UBS forecasts a full year FY27 dividend of 358.00 cents and EPS of 509.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 522.0, implying annual growth of 13.5%. Current consensus DPS estimate is 365.2, implying a prospective dividend yield of 2.6%. Current consensus EPS estimate suggests the PER is 27.0. |
Market Sentiment: -0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CSL CSL LIMITED
Pharmaceuticals & Biotech/Lifesciences
More Research Tools In Stock Analysis - click HERE
Overnight Price: $134.60
Macquarie rates CSL as Neutral (3) -
First take:
Macquarie's first assessment is that today's FY26 result from CSL has met expectations while FY27 guidance is ahead of forecasts by between 3%-5%.
Commentary highlights the buyback has increased to US$1.1bn in FY27 (US$1bn in FY26), while 50% of incremental savings from the transformation program will be reinvested in growth opportunities (i.e. US$100m).
Neutral. Target $108.
Target price is $108.00 Current Price is $134.60 Difference: minus $26.6 (current price is over target).
If CSL meets the Macquarie target it will return approximately minus 20% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $132.84, suggesting downside of -16.3% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY26:
Macquarie forecasts a full year FY26 dividend of 420.19 cents and EPS of 923.55 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 897.1, implying annual growth of N/A. Current consensus DPS estimate is 405.2, implying a prospective dividend yield of 2.6%. Current consensus EPS estimate suggests the PER is 17.7. |
Forecast for FY27:
Macquarie forecasts a full year FY27 dividend of 424.57 cents and EPS of 926.47 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 902.1, implying annual growth of 0.6%. Current consensus DPS estimate is 414.5, implying a prospective dividend yield of 2.6%. Current consensus EPS estimate suggests the PER is 17.6. |
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
UBS rates CSL as Buy (1) -
First take:
It is UBS's first assessment that CSL's FY26 release is in line with revised guidance while FY27 guidance looks like it is slightly better than consensus expectations.
Better than forecast Ig and albumin sales plus strong sales and gross margin for Vifor are underpinning today's positive surprise, commentary highlights.
The broker also notes -US$5.4bn of impairments were booked, which is above expectations, but commentary suggests this will ensure a cleaner FY27 result.
Buy rating with a $158 target.
Target price is $158.00 Current Price is $134.60 Difference: $23.4
If CSL meets the UBS target it will return approximately 17% (excluding dividends, fees and charges).
Current consensus price target is $132.84, suggesting downside of -16.3% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY26:
UBS forecasts a full year FY26 dividend of 423.11 cents and EPS of 919.17 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 897.1, implying annual growth of N/A. Current consensus DPS estimate is 405.2, implying a prospective dividend yield of 2.6%. Current consensus EPS estimate suggests the PER is 17.7. |
Forecast for FY27:
UBS forecasts a full year FY27 dividend of 423.11 cents and EPS of 942.52 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 902.1, implying annual growth of 0.6%. Current consensus DPS estimate is 414.5, implying a prospective dividend yield of 2.6%. Current consensus EPS estimate suggests the PER is 17.6. |
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $1.35
Ord Minnett rates CUP as Initiation of coverage with Buy (1) -
Count is one of the largest integrated financial advice and accounting businesses in Australia. It has three operating segments: equity partnerships (52% of group revenues); wealth (29%); and services (19%).
The equity partnerships business comprises Count's equity stakes in approximately 500 accounting and advice firms. Count appears well-placed to benefit from a number of structural tailwinds, Ord Minnett suggests.
Ord Minnett initiates coverage with a Buy rating and target price of $2.00.
Target price is $2.00 Current Price is $1.35 Difference: $0.65
If CUP meets the Ord Minnett target it will return approximately 48% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY26:
Ord Minnett forecasts a full year FY26 dividend of 5.00 cents and EPS of 7.00 cents. |
Forecast for FY27:
Ord Minnett forecasts a full year FY27 dividend of 6.00 cents and EPS of 9.00 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
DOC DOCTOR CARE ANYWHERE GROUP PLC
Software & Services
More Research Tools In Stock Analysis - click HERE
Overnight Price: $0.12
Bell Potter rates DOC as Buy (1) -
Bell Potter maintains a Buy rating for Doctor Care Anywhere with its target price decreased to $0.22 from $0.24 following 1H26 financial results that included revenues of GBP20.4m.
The analyst notes revenue expanded 6% year-on-year, inclusive of GBP0.9m from the recently completed Medicspot acquisition, while underlying EBITDA improved 24% to GBP2.6m and free cash flow more than doubled to GBP1.5m.
The broker's estimates incorporate minor earnings adjustments alongside target price dilution stemming from options included in the capital base.
Management highlights the strategic focus remains centred on scaling the higher-margin B2B corporate wellness market and integrating Medicspot's weight-management suite.
Major catalysts depend on corporate wellbeing tender wins and a planned brand re-launch in 2H26.
Target price is $0.22 Current Price is $0.12 Difference: $0.1
If DOC meets the Bell Potter target it will return approximately 83% (excluding dividends, fees and charges).
The company's fiscal year ends in December.
Forecast for FY26:
Bell Potter forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.98 cents. |
Forecast for FY27:
Bell Potter forecasts a full year FY27 dividend of 0.00 cents and EPS of 0.78 cents. |
This company reports in GBP. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
EDV ENDEAVOUR GROUP LIMITED
Food, Beverages & Tobacco
More Research Tools In Stock Analysis - click HERE
Overnight Price: $3.52
Bell Potter rates EDV as Downgrade to Hold from Buy (3) -
Bell Potter downgrades its rating for Endeavour Group to Hold from Buy with its target price decreased to $3.60 from $3.85 following the release of FY26 results.
The analyst highlights persistent retail headwinds and competitive pricing pressures impacting margins across the drinks and hospitality divisions.
The broker's estimates adjust earnings projections downwards to account for softer top-line momentum and ongoing cost inflation.
Management continues to focus on cost optimisation and store network efficiency to defend market share amid a cautious consumer backdrop.
The analyst views current valuation levels as fair, reflecting a balanced risk-reward profile across the forecast period.
Target price is $3.60 Current Price is $3.52 Difference: $0.08
If EDV meets the Bell Potter target it will return approximately 2% (excluding dividends, fees and charges).
Current consensus price target is $3.22, suggesting downside of -6.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY26:
Bell Potter forecasts a full year FY26 dividend of 15.00 cents and EPS of 20.60 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 20.3, implying annual growth of -14.7%. Current consensus DPS estimate is 14.2, implying a prospective dividend yield of 4.1%. Current consensus EPS estimate suggests the PER is 16.9. |
Forecast for FY27:
Bell Potter forecasts a full year FY27 dividend of 16.50 cents and EPS of 21.20 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 20.2, implying annual growth of -0.5%. Current consensus DPS estimate is 12.8, implying a prospective dividend yield of 3.7%. Current consensus EPS estimate suggests the PER is 17.0. |
Market Sentiment: -0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $13.89
Citi rates EVN as Neutral (3) -
Citi updates its gold coverage post the June quarter results. The commodities team remains bullish on the gold price with the 6-12 months target unchanged at US$5,000/oz.
The FY27 AUD gold price forecast is lowered by around -9%, which is noted as "phasing" and not a change in the structural view.
The broker cuts FY27 EBITDA forecasts by around -20%, excluding Evolution Mining, which is lowered -5%. FY27 and FY28 AISC estimates rise around 4%-12%, reflecting higher diesel costs as Brent crude is up 34% YoY.
Target price falls to $13.70 from $15. No change to Neutral rating.
Target price is $13.70 Current Price is $13.89 Difference: minus $0.19 (current price is over target).
If EVN meets the Citi target it will return approximately minus 1% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $13.45, suggesting downside of -0.6% (ex-dividends)
Forecast for FY26:
Current consensus EPS estimate is 81.9, implying annual growth of 76.1%. Current consensus DPS estimate is 40.8, implying a prospective dividend yield of 3.0%. Current consensus EPS estimate suggests the PER is 16.5. |
Forecast for FY27:
Current consensus EPS estimate is 96.1, implying annual growth of 17.3%. Current consensus DPS estimate is 47.2, implying a prospective dividend yield of 3.5%. Current consensus EPS estimate suggests the PER is 14.1. |
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $3.70
Morgans rates FDC as Initiation of coverage with Accumulate (2) -
Morgans initiates coverage of FDC Consolidated, viewing the construction and building services contractor as a quality earnings compounder with strong revenue visibility.
The company's relationship-led model is highlighted, with around 66% of work secured through non-tendered channels, supporting repeat business and margins.
Morgans forecasts around 12% annual revenue and profit growth over FY25-FY28, with circa 71% of FY27 revenue already secured.
A capital-light model and strong net cash position are seen as supporting free cash flow (FCF), an around 80% dividend payout ratio and a yield above 5%.
Morgans starts with an Accumulate rating and $3.97 target.
Target price is $3.97 Current Price is $3.70 Difference: $0.27
If FDC meets the Morgans target it will return approximately 7% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY26:
Morgans forecasts a full year FY26 dividend of 0.00 cents and EPS of 22.00 cents. |
Forecast for FY27:
Morgans forecasts a full year FY27 dividend of 20.00 cents and EPS of 24.00 cents. |
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
FRW FREIGHTWAYS GROUP LIMITED
Transportation & Logistics
More Research Tools In Stock Analysis - click HERE
Overnight Price: $11.91
Macquarie rates FRW as Outperform (1) -
Macquarie views Freightways' FY26 result as resilient, with strong earnings growth despite softer trading in the final quarter. Revenue rose 13.5%, earnings (EBITA) increased 14.6% and profit grew 17.3%, while the FY26 dividend increased 12.5%.
The broker notes higher fuel prices and weaker customer demand interrupted the volume recovery from April, shifting the recovery story into FY27.
Australian scale, a full-year Velociti Freight Express (VTFE) contribution, margin initiatives and a recovery in New Zealand volumes are seen as key FY27 earnings drivers.
Macquarie lowers its FY27 EPS forecast by around -4%, with minimal changes thereafter. Unchanged Outperform rating and NZ$15.65 target.
Current Price is $11.91. Target price not assessed.
Current consensus price target is $13.20, suggesting upside of 10.8% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Macquarie forecasts a full year FY27 dividend of 44.47 cents and EPS of 52.63 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 52.5, implying annual growth of N/A. Current consensus DPS estimate is 42.6, implying a prospective dividend yield of 3.6%. Current consensus EPS estimate suggests the PER is 22.7. |
Forecast for FY28:
Macquarie forecasts a full year FY28 dividend of 62.90 cents and EPS of 75.90 cents. |
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Ord Minnett rates FRW as Downgrade to Accumulate from Buy (2) -
Freightways recorded FY26 profit up 17%, beating Ord Minnett's expectations by 3%.
More evidence of market share gains in the Express A&NZ segments has been overshadowed by steadily softening B2B and B2C conditions since May, the broker notes.
Combined with a surprise bump in operating costs associated with the billing system upgrade, Ord Minnett has taken a conservative view on the outlook and lowered FY27 earnings forecasts by –8%.
This leads to a downgrade to Accumulate from Buy. Target falls to $13.20 from $13.87.
Target price is $13.20 Current Price is $11.91 Difference: $1.29
If FRW meets the Ord Minnett target it will return approximately 11% (excluding dividends, fees and charges).
Current consensus price target is $13.20, suggesting upside of 10.8% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Ord Minnett forecasts a full year FY27 dividend of 43.36 cents and EPS of 51.27 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 52.5, implying annual growth of N/A. Current consensus DPS estimate is 42.6, implying a prospective dividend yield of 3.6%. Current consensus EPS estimate suggests the PER is 22.7. |
Forecast for FY28:
Ord Minnett forecasts a full year FY28 dividend of 45.91 cents and EPS of 58.58 cents. |
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
UBS rates FRW as Neutral (3) -
UBS retains a Neutral rating on Freightways Group following FY26 results, with the broker viewing the outlook for stronger earnings growth as largely reflected in the share price.
Allied Express delivered a stronger than expected 2H result, supported by 20% volume growth and margin expansion, offsetting softer contributions from NZ Express Package and Information Management.
The analyst expects more limited margin expansion in FY27 as Express Package volumes remain subdued and IT spending increases, although EPS growth is still forecast at 12% for the year.
EPS forecasts are lowered -3% to -5% across FY27 to FY29, with stronger Allied Express earnings offset by downgrades elsewhere. The target price falls to NZ$14.30 from NZ$14.45, with the rating unchanged at Neutral.
Current Price is $11.91. Target price not assessed.
Current consensus price target is $13.20, suggesting upside of 10.8% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
UBS forecasts a full year FY27 dividend of 43.36 cents and EPS of 57.82 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 52.5, implying annual growth of N/A. Current consensus DPS estimate is 42.6, implying a prospective dividend yield of 3.6%. Current consensus EPS estimate suggests the PER is 22.7. |
Forecast for FY28:
UBS forecasts a full year FY28 dividend of 59.00 cents and EPS of 79.00 cents. |
This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $12.44
Citi rates GGP as Buy (1) -
Citi updates its gold coverage post the June quarter results. The commodities team remains bullish on the gold price with the 6-12 months target unchanged at US$5,000/oz.
The FY27 AUD gold price forecast is lowered by around -9%, which is noted as "phasing" and not a change in the structural view.
The broker cuts FY27 EBITDA forecasts by around -20%, excluding Evolution Mining ((EVN)), which is lowered -5%. FY27 and FY28 AISC estimates rise around 4%-12%, reflecting higher diesel costs as Brent crude is up 34% YoY.
Greatland Resources remains Buy rated with a lower target of $14 from $16.
Target price is $14.00 Current Price is $12.44 Difference: $1.56
If GGP meets the Citi target it will return approximately 13% (excluding dividends, fees and charges).
Current consensus price target is $14.56, suggesting upside of 17.3% (ex-dividends)
Forecast for FY26:
Current consensus EPS estimate is 126.7, implying annual growth of 99.3%. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is 9.8. |
Forecast for FY27:
Current consensus EPS estimate is 92.5, implying annual growth of -27.0%. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is 13.4. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $7.50
Citi rates GMD as Buy (1) -
Citi updates its gold coverage post the June quarter results. The commodities team remains bullish on the gold price with the team 6-12 months target unchanged at US$5,000/oz.
The FY27 AUD gold price forecast is lowered by around –9%, which is noted as "phasing" and not a change in the structural view.
The broker cuts FY27 EBITDA forecasts by around –20%, excluding Evolution Mining ((EVN)), which is lowered –5%. FY27 and FY28 AISC estimates rise around 4%–12%, reflecting higher diesel costs as Brent crude is up 34% YoY.
Genesis Minerals remains the preferred exposure with a Buy rating and a lower target of $8.60 from $10.
Target price is $8.60 Current Price is $7.50 Difference: $1.1
If GMD meets the Citi target it will return approximately 15% (excluding dividends, fees and charges).
Current consensus price target is $8.50, suggesting upside of 16.0% (ex-dividends)
Forecast for FY26:
Current consensus EPS estimate is 48.3, implying annual growth of 138.3%. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is 15.2. |
Forecast for FY27:
Current consensus EPS estimate is 56.0, implying annual growth of 15.9%. Current consensus DPS estimate is 1.5, implying a prospective dividend yield of 0.2%. Current consensus EPS estimate suggests the PER is 13.1. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
GOZ GROWTHPOINT PROPERTIES AUSTRALIA
Infra & Property Developers
More Research Tools In Stock Analysis - click HERE
Overnight Price: $2.16
Citi rates GOZ as Buy (1) -
Citi believes Growthpoint Properties Australia continues to remain a relative "value" stock and the upcoming Woolworths Group's ((WOW)) distribution centre sale will facilitate a reduction in gearing by around -4%.
The stock is trading at circa -30% discount to NTA of $3.10 and an 8.8% yield. Buy. Target $2.60.
First take:
On first glance, Citi reports Growthpoint Properties Australia delivered FY26 funds from operations ahead of consensus, supported by record office leasing that lifted occupancy to 96% – the best in years.
FY27 FFO guidance is a step down from FY26 but broadly in line with Citi's estimate, suggesting the top end remains achievable. The pending Woolworths distribution centre divestment will reduce gearing by -4%, providing welcome balance sheet relief at 41.6% gearing.
Trading at a -30% discount to reported net tangible asset valuation and offering a forward yield of 8.8%, Growthpoint remains a relative value stock, Citi suggests. Buy and $2.60 target retained.
Target price is $2.60 Current Price is $2.16 Difference: $0.44
If GOZ meets the Citi target it will return approximately 20% (excluding dividends, fees and charges).
Forecast for FY27:
Forecast for FY28:
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Macquarie rates GOZ as Outperform (1) -
Growthpoint Properties Australia's FY26 result was broadly in line with Macquarie's forecasts, with funds from operations per security (FFOps) of 23.5c near the top of management guidance.
FY27 FFOps guidance of 22.6c–23.5c and distribution guidance of 18.4cpu were also in line with the broker's expectations, with office leasing the key swing factor.
The distribution payout ratio was around 78% of funds from operations (FFO) in FY25 and FY26, though Macquarie estimates a ratio closer to 70% would be more sustainable.
The broker notes Growthpoint trades at a -29% discount to net tangible assets (NTA) of $3.05 and offers an attractive FY27 distribution yield.
Commentary notes higher interest rates weigh on the outlook, though a recent $267.7m asset sale should reduce gearing by around -4 percentage points. Macquarie lowers its target to $2.30 from $2.47 and retains an Outperform rating.
Target price is $2.30 Current Price is $2.16 Difference: $0.14
If GOZ meets the Macquarie target it will return approximately 6% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY27:
Macquarie forecasts a full year FY27 dividend of 18.40 cents and EPS of 16.20 cents. |
Forecast for FY28:
Macquarie forecasts a full year FY28 dividend of 17.60 cents and EPS of 16.80 cents. |
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $5.00
Citi rates GPT as Buy (1) -
Citi views GPT Group's FY26 as a "quality" result with the strength in the retail portfolio the standout. The analyst highlights management's focus on actively managing each of the core real estate assets, while advancing its third-party platform.
Trading around a -7.2% discount to NTA of $5.61, the broker reiterates its Buy rating. Target unchanged at $6.
First Take: GPT Group's 1H26 FFO of 17.7cps was ahead of Citi's forecast and consensus, supported by strong retail, office and logistics performance.
FUM rose 4.6% to $41.6bn, with the analyst highlighting strong investor demand for the $697m equity raising as supportive of future fee income growth.
Retail occupancy reached 99.8% with positive specialty lease spreads of 6.6%, while logistics lease spreads were 38%.
FY26 FFO guidance of circa 35.4cps is marginally below Citi's 35.6cps forecast, although the broker considers guidance conservative given 1H momentum.
The result is in line and viewed as "reassuring" which should be supported by investors, commentary suggests. Buy. Target $6.
Target price is $6.00 Current Price is $5.00 Difference: $1
If GPT meets the Citi target it will return approximately 20% (excluding dividends, fees and charges).
Current consensus price target is $5.53, suggesting upside of 15.2% (ex-dividends)
Forecast for FY26:
Current consensus EPS estimate is 35.5, implying annual growth of -30.7%. Current consensus DPS estimate is 24.7, implying a prospective dividend yield of 5.1%. Current consensus EPS estimate suggests the PER is 13.5. |
Forecast for FY27:
Current consensus EPS estimate is 36.5, implying annual growth of 2.8%. Current consensus DPS estimate is 25.4, implying a prospective dividend yield of 5.3%. Current consensus EPS estimate suggests the PER is 13.2. |
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Macquarie rates GPT as Downgrade to Neutral from Outperform (3) -
GPT Group's interim funds from operations per security (FFOps) came in modestly ahead of Macquarie's expectations and strong like-for-like property income growth.
Investment portfolio growth of 5.8% was broad-based, led by Office at 8%, while FY26 FFOps and distribution guidance were reaffirmed.
The broker expects adjusted funds from operations (AFFO) growth to accelerate in FY27 as office incentives peak, though rising debt costs present a medium-term headwind.
Forecast changes are immaterial, while higher bond yields drive an 18bp expansion in Macquarie's assumed capitalisation rates.
Macquarie lowers its target to $5.10 from $5.37 and downgrades to Neutral from Outperform.
Target price is $5.10 Current Price is $5.00 Difference: $0.1
If GPT meets the Macquarie target it will return approximately 2% (excluding dividends, fees and charges).
Current consensus price target is $5.53, suggesting upside of 15.2% (ex-dividends)
The company's fiscal year ends in December.
Forecast for FY26:
Macquarie forecasts a full year FY26 dividend of 24.50 cents and EPS of 35.40 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 35.5, implying annual growth of -30.7%. Current consensus DPS estimate is 24.7, implying a prospective dividend yield of 5.1%. Current consensus EPS estimate suggests the PER is 13.5. |
Forecast for FY27:
Macquarie forecasts a full year FY27 dividend of 24.80 cents and EPS of 36.60 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 36.5, implying annual growth of 2.8%. Current consensus DPS estimate is 25.4, implying a prospective dividend yield of 5.3%. Current consensus EPS estimate suggests the PER is 13.2. |
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Ord Minnett rates GPT as Accumulate (2) -
GPT Group reported funds from operations of 17.7c in the first half, up 5.4% year on year. An interim distribution of 12.25c, up 2.1%, was previously announced. The result puts GPT on track to achieve its reaffirmed FY26 FFO and distribution guidance, Ord Minnett notes.
Net gearing of 31.5%, albeit up slightly from 30.7%, remains within the target range of 25%-35%, and GPT has $1.0bn of available liquidity as at end-June.
Ord Minnett sees scope for GPT to upgrade its FFO guidance and accordingly raises its forecast to 0.9% above guidance. The broker's target price is trimmed to $5.15 from $5.30 as adjusted FFO (which includes maintenance capex and incentives) is lowered slightly.
Accumulate retained.
Target price is $5.15 Current Price is $5.00 Difference: $0.15
If GPT meets the Ord Minnett target it will return approximately 3% (excluding dividends, fees and charges).
Current consensus price target is $5.53, suggesting upside of 15.2% (ex-dividends)
The company's fiscal year ends in December.
Forecast for FY26:
Ord Minnett forecasts a full year FY26 dividend of 24.50 cents and EPS of 36.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 35.5, implying annual growth of -30.7%. Current consensus DPS estimate is 24.7, implying a prospective dividend yield of 5.1%. Current consensus EPS estimate suggests the PER is 13.5. |
Forecast for FY27:
Ord Minnett forecasts a full year FY27 dividend of 25.00 cents and EPS of 37.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 36.5, implying annual growth of 2.8%. Current consensus DPS estimate is 25.4, implying a prospective dividend yield of 5.3%. Current consensus EPS estimate suggests the PER is 13.2. |
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
UBS rates GPT as Buy (1) -
On further inspection, the 1H26 earnings beat and strong operational performance saw the shares fall -2.5% as investors focused on lower office occupancy and the absence of new funds management growth initiatives.
The analyst remains confident in further third party FUM growth and sees scope for Grosvenor occupancy to improve from 70.6%.
EPS forecasts are tweaked with FY26 EPS sitting ahead of guidance at 35.5c. Target price sits at $5.60, unchanged with a Buy rating.
First Take: GPT Group's 1H26 FFO of $338.8m, or 17.7cps, was 2% ahead of UBS and 1% ahead of consensus, de-risking FY26 guidance.
Retail remained strong with 99.8% occupancy and 6.6% leasing spreads, while logistics occupancy was 98.9% with leasing spreads of 38%.
UBS highlights softer office metrics, with occupancy falling to 92.1% and Grosvenor Place at 70.6%, although office like-for-like NOI grew 8%.
FY26 guidance is unchanged at 35.4cps FFO and 24.5cps DPS.
Buy. Target $5.60.
Target price is $5.60 Current Price is $5.00 Difference: $0.6
If GPT meets the UBS target it will return approximately 12% (excluding dividends, fees and charges).
Current consensus price target is $5.53, suggesting upside of 15.2% (ex-dividends)
The company's fiscal year ends in December.
Forecast for FY26:
UBS forecasts a full year FY26 dividend of 25.00 cents and EPS of 35.50 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 35.5, implying annual growth of -30.7%. Current consensus DPS estimate is 24.7, implying a prospective dividend yield of 5.1%. Current consensus EPS estimate suggests the PER is 13.5. |
Forecast for FY27:
UBS forecasts a full year FY27 dividend of 26.00 cents and EPS of 35.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 36.5, implying annual growth of 2.8%. Current consensus DPS estimate is 25.4, implying a prospective dividend yield of 5.3%. Current consensus EPS estimate suggests the PER is 13.2. |
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $2.40
Macquarie rates GWA as Neutral (3) -
Macquarie assesses GWA Group's FY26 result as "solid", with revenue in line and earnings (EBIT) slightly ahead of expectations despite a softer second half.
Australian growth was supported by Merchant, Multi-Residential and Win the Plumber performing well, while detached housing, renovations and commercial markets remained subdued, the analyst explains.
Win the Plumber is a strategic initiative aimed at increasing preference and loyalty amongst plumbers for its brands and products.
The broker expects a mixed FY27 outlook, with higher pricing helping offset cost pressures and cash conversion recovering as inventory unwinds.
Macquarie lowers FY27-FY29 EPS forecasts by -1.4%-3.8%, reflecting higher costs and pricing decisions, partly offset by stronger near-term volumes. The target is raised to $2.30 from $2.15. Neutral rating maintained.
Target price is $2.30 Current Price is $2.40 Difference: minus $0.1 (current price is over target).
If GWA meets the Macquarie target it will return approximately minus 4% (excluding dividends, fees and charges - negative figures indicate an expected loss).
The company's fiscal year ends in June.
Forecast for FY27:
Macquarie forecasts a full year FY27 dividend of 16.50 cents and EPS of 19.20 cents. |
Forecast for FY28:
Macquarie forecasts a full year FY28 dividend of 16.50 cents and EPS of 20.40 cents. |
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $3.69
Bell Potter rates IMD as Downgrade to Hold from Buy (3) -
Bell Potter downgrades its rating for Imdex to Hold from Buy with its target price decreased to $4.00 from $4.60 following an expense overshoot in the FY26 result.
The company reported underlying EBITDA of $163m, up 29% year-on-year and 4% ahead of the broker's forecast, supported by strong Platform Enabled Hardware Rentals and Integrated On-Site Services.
Higher-than-expected expenses, depreciation, and net finance costs led to earnings revisions and a reduced target price.
The broker's estimates adjust FY27 and FY28 earnings projections downwards to reflect increased cost hurdles and a higher capital expenditure profile.
The analyst notes that current market valuations leave limited upside potential, warranting a more cautious stance across the forecast period.
Target price is $4.00 Current Price is $3.69 Difference: $0.31
If IMD meets the Bell Potter target it will return approximately 8% (excluding dividends, fees and charges).
Current consensus price target is $4.59, suggesting upside of 21.7% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Bell Potter forecasts a full year FY27 dividend of 3.70 cents and EPS of 11.80 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 13.9, implying annual growth of N/A. Current consensus DPS estimate is 4.0, implying a prospective dividend yield of 1.1%. Current consensus EPS estimate suggests the PER is 27.1. |
Forecast for FY28:
Bell Potter forecasts a full year FY28 dividend of 4.70 cents and EPS of 14.90 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 16.2, implying annual growth of 16.5%. Current consensus DPS estimate is 4.7, implying a prospective dividend yield of 1.2%. Current consensus EPS estimate suggests the PER is 23.3. |
Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Macquarie rates IMD as Outperform (1) -
Imdex posted record FY26 revenue, up 21% year on year, and 29% earnings growth with more than 50% of growth driven by market share gains rather than exploration activity, Macquarie notes.
Share of wallet reached $2.40 per $100 of exploration spend, up from $2.20 a year ago. Growth was broad-based across regions, supported by strong integrated services uptake, increased adoption of next-generation technologies and accelerating digital revenue.
In FY27 Imdex will prioritise acquisition integration, platform scaling and AI investment, which is reflected in consensus with earnings margins flat versus FY26. However, higher D&A and interest expense will likely temper profit upgrades post result, the broker suggests.
While investment will step up in FY27, it should position Imdex for accelerated growth medium term, underpinned by market share gains, tech adoption, and strategic M&A. Macquarie retains Outperform, target rises to $5.00 from $4.60.
Target price is $5.00 Current Price is $3.69 Difference: $1.31
If IMD meets the Macquarie target it will return approximately 36% (excluding dividends, fees and charges).
Current consensus price target is $4.59, suggesting upside of 21.7% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Macquarie forecasts a full year FY27 dividend of 4.20 cents and EPS of 13.90 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 13.9, implying annual growth of N/A. Current consensus DPS estimate is 4.0, implying a prospective dividend yield of 1.1%. Current consensus EPS estimate suggests the PER is 27.1. |
Forecast for FY28:
Macquarie forecasts a full year FY28 dividend of 4.80 cents and EPS of 15.90 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 16.2, implying annual growth of 16.5%. Current consensus DPS estimate is 4.7, implying a prospective dividend yield of 1.2%. Current consensus EPS estimate suggests the PER is 23.3. |
Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Morgans rates IMD as Downgrade to Accumulate from Buy (2) -
Imdex's FY26 earnings (EBITDA) rose 29% and profit increased by 34%, broadly in line with Morgans' forecasts. The broker was, however, disappointed by higher integration, depreciation and finance costs, which weigh on the outlook below the earnings line.
The analyst leaves his FY27 EBITDA forecast unchanged at $200m, believing the market continues to underestimate operating leverage in the core business.
The FY27 profit forecast is lowered by -2% on higher interest costs, while earnings growth is expected to moderate to 16% from 34% in FY26. The target is lowered to $4.30 from $5.00 and the rating downgraded to Accumulate from Buy.
Target price is $4.30 Current Price is $3.69 Difference: $0.61
If IMD meets the Morgans target it will return approximately 17% (excluding dividends, fees and charges).
Current consensus price target is $4.59, suggesting upside of 21.7% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Morgans forecasts a full year FY27 dividend of 3.90 cents and EPS of 15.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 13.9, implying annual growth of N/A. Current consensus DPS estimate is 4.0, implying a prospective dividend yield of 1.1%. Current consensus EPS estimate suggests the PER is 27.1. |
Forecast for FY28:
Morgans forecasts a full year FY28 dividend of 4.30 cents and EPS of 16.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 16.2, implying annual growth of 16.5%. Current consensus DPS estimate is 4.7, implying a prospective dividend yield of 1.2%. Current consensus EPS estimate suggests the PER is 23.3. |
Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
UBS rates IMD as Buy (1) -
On further inspection, the analyst points out the ongoing positive outlook for exploration is likely to result in a prolonged upcycle which could result in volume and price upside.
The broker retains a positive view on exploration and Imdex's reputation as a market leader. UBS remains Buy rated with a lower target of $5.05 from $5.15.
First Take: Imdex's FY26 EBITDA was 2% ahead of UBS and consensus, with the EBITDA margin of 31.3% around 50-60 bps above expectations.
Organic revenue grew 17% and share of wallet increased to a record 2.4%, reflecting increased adoption of the company's integrated solutions.
Notably, tools on hire reached a record, with next-generation tools increasing to 12% of the fleet and offering further pricing upside.
UBS expects Imdex to continue outpacing the market, while strong cash generation should reduce leverage from the current 1.3x following recent acquisitions.
Buy. Target $5.15.
Target price is $5.05 Current Price is $3.69 Difference: $1.36
If IMD meets the UBS target it will return approximately 37% (excluding dividends, fees and charges).
Current consensus price target is $4.59, suggesting upside of 21.7% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
UBS forecasts a full year FY27 dividend of 4.00 cents and EPS of 15.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 13.9, implying annual growth of N/A. Current consensus DPS estimate is 4.0, implying a prospective dividend yield of 1.1%. Current consensus EPS estimate suggests the PER is 27.1. |
Forecast for FY28:
UBS forecasts a full year FY28 dividend of 5.00 cents and EPS of 18.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 16.2, implying annual growth of 16.5%. Current consensus DPS estimate is 4.7, implying a prospective dividend yield of 1.2%. Current consensus EPS estimate suggests the PER is 23.3. |
Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
IRE IRESS LIMITED
Wealth Management & Investments
More Research Tools In Stock Analysis - click HERE
Overnight Price: $6.99
Macquarie rates IRE as Outperform (1) -
Iress posted first half recurring revenue up 3.4% and cash earnings up 34%, supported by opex and below-trend capex, yet the overall result was below Macquarie's forecasts.
2026 revenue guidance is downgraded -4.2% and profit -3.4% impacted by lower non-recurring revenue and FX headwind. The business efficiency program has delivered $31.5m of annualised cost savings, including $14.5m in 1H26 and a further $6m-$9m expected in 2H26.
On the negative side, Macquarie notes non-recurring revenue was down -14.1% year on year due to completion of large client projects (particularly the multi-year UK client program).
Macquarie sees the potential for Iress to drive margin expansion and earnings over time. The view is further supported by valuation appeal, upside risk to earnings expectations and the group's entrenched market position.
Target rises to $7.72 from $7.65, Outperform retained.
Target price is $7.72 Current Price is $6.99 Difference: $0.73
If IRE meets the Macquarie target it will return approximately 10% (excluding dividends, fees and charges).
Current consensus price target is $9.66, suggesting upside of 50.9% (ex-dividends)
The company's fiscal year ends in December.
Forecast for FY26:
Macquarie forecasts a full year FY26 dividend of 29.00 cents and EPS of 42.50 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 43.3, implying annual growth of 1.5%. Current consensus DPS estimate is 28.5, implying a prospective dividend yield of 4.5%. Current consensus EPS estimate suggests the PER is 14.8. |
Forecast for FY27:
Macquarie forecasts a full year FY27 dividend of 32.00 cents and EPS of 45.60 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 46.3, implying annual growth of 6.9%. Current consensus DPS estimate is 31.5, implying a prospective dividend yield of 4.9%. Current consensus EPS estimate suggests the PER is 13.8. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Morgans rates IRE as Buy (1) -
First-half FY26 results for Iress were softer than expected by Morgans, with weaker revenue momentum and currency headwinds offset by improving cost efficiency.
Revenue and underlying earnings (EBITDA) missed the broker's forecasts by -2% and -4%, respectively, though the underlying earnings margin improved 330bps as cost savings flowed through.
FY26 revenue and underlying profit guidance was lowered, but cash EBITDA guidance increased to $119m-$124m, supported by further cost savings and lower capex, the analyst explains.
The broker lowers its FY26-FY28 underlying profit forecasts by -2%-6%, while believing the broader efficiency and modernisation strategy remains on track. Target falls to $9.65 from $10.35. Buy rating maintained.
Target price is $9.65 Current Price is $6.99 Difference: $2.66
If IRE meets the Morgans target it will return approximately 38% (excluding dividends, fees and charges).
Current consensus price target is $9.66, suggesting upside of 50.9% (ex-dividends)
The company's fiscal year ends in December.
Forecast for FY26:
Morgans forecasts a full year FY26 dividend of 28.00 cents and EPS of 44.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 43.3, implying annual growth of 1.5%. Current consensus DPS estimate is 28.5, implying a prospective dividend yield of 4.5%. Current consensus EPS estimate suggests the PER is 14.8. |
Forecast for FY27:
Morgans forecasts a full year FY27 dividend of 31.00 cents and EPS of 47.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 46.3, implying annual growth of 6.9%. Current consensus DPS estimate is 31.5, implying a prospective dividend yield of 4.9%. Current consensus EPS estimate suggests the PER is 13.8. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $71.65
Bell Potter rates JBH as Buy (1) -
Bell Potter maintains a Buy rating for JB Hi-Fi with its target price decreased to $81.00 from $87.00 following an FY26 result that was broadly in line with expectations.
Group sales revenue reached $11,064.0m, up 4.8% year-on-year, while underlying net profit after tax grew 5.0% to $489.9m.
The analyst notes July trading data for the start of FY27 was softer, with comparable sales contracting across the Australian JB Hi-Fi, The Good Guys, and E&S divisions amid ongoing supplier price increases and stock availability challenges in technology categories.
The broker's estimates adjust FY27 earnings downwards by approximately 6% to reflect a softer first-half trading environment before a projected recovery in the second half driven by less challenging comparables.
Commentary highlights that management remains optimistic regarding upcoming peak promotional periods and new product releases, supported by high productivity-driven unit economics and solid market share resilience.
Target price is $81.00 Current Price is $71.65 Difference: $9.35
If JBH meets the Bell Potter target it will return approximately 13% (excluding dividends, fees and charges).
Current consensus price target is $78.93, suggesting upside of 10.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Bell Potter forecasts a full year FY27 dividend of 336.00 cents and EPS of 418.20 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 433.5, implying annual growth of N/A. Current consensus DPS estimate is 334.6, implying a prospective dividend yield of 4.7%. Current consensus EPS estimate suggests the PER is 16.5. |
Forecast for FY28:
Bell Potter forecasts a full year FY28 dividend of 290.00 cents and EPS of 454.40 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 459.5, implying annual growth of 6.0%. Current consensus DPS estimate is 338.6, implying a prospective dividend yield of 4.7%. Current consensus EPS estimate suggests the PER is 15.6. |
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Citi rates JBH as Neutral (1) -
On further inspection, Citi downgrades JB Hi-Fi to Neutral from Buy with a lower target of $77 from $85.
EBIT forecasts are cut by circa –5% to –8% for FY27–FY28 on reduced sales growth expectations and less operating leverage.
Commentary posits the softening in like-for-like sales growth from 3Q26 into July confirms the retailer can no longer grow sales positively through the economic cycle, and secondly the consumer backdrop has "deteriorated".
At current valuations around 16x, the analyst does not consider the stock to be cheap enough against its historical valuation of between around 10x–20x.
First Take: JB Hi-Fi's FY26 EBIT of $734m was some –2% below Citi and –1% below consensus expectations, largely due to weaker sales, the analyst remarks.
JB Hi-Fi Australia underperformed, while The Good Guys and NZ were slightly ahead of the broker's expectations.
July trading weakened, with like-for-like sales down –1.4% at JB Hi-Fi Australia and –1.7% at The Good Guys, while NZ remained strong with 11.7% growth.
July trading is below consensus expectations for 1H27 and the analyst expects the result to weigh on the share price.
The final dividend of 127cps was below Citi's 133cps forecast.
Buy. Target $85.
Target price is $77.00 Current Price is $71.65 Difference: $5.35
If JBH meets the Citi target it will return approximately 7% (excluding dividends, fees and charges).
Current consensus price target is $78.93, suggesting upside of 10.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Citi forecasts a full year FY27 dividend of 330.00 cents and EPS of 438.50 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 433.5, implying annual growth of N/A. Current consensus DPS estimate is 334.6, implying a prospective dividend yield of 4.7%. Current consensus EPS estimate suggests the PER is 16.5. |
Forecast for FY28:
Citi forecasts a full year FY28 dividend of 352.00 cents and EPS of 466.80 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 459.5, implying annual growth of 6.0%. Current consensus DPS estimate is 338.6, implying a prospective dividend yield of 4.7%. Current consensus EPS estimate suggests the PER is 15.6. |
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Macquarie rates JBH as Outperform (1) -
JB Hi-Fi's FY26 earnings and profit were -1% below consensus. Macquarie expects negative earnings revisions based on the trading update.
Management noted growth has been impacted by elevated supplier price rises and stock availability shortages, which have lingered into early FY27. In the broker's view, current sales momentum does not reflect underlying strength of the business.
Despite these near-term headwinds, Macquarie sees a pathway to sales momentum improving as tailwinds in the prior period alleviate and market dynamics normalise.
Noting short-term sales volatility, JB Hi-Fi has executed well in a challenging environment, the broker believes. Growth prospects of the consumer electronics category and strength of the business are unchanged despite short-term concerns.
Target falls to $94 from $98, Outperform retained.
Target price is $94.00 Current Price is $71.65 Difference: $22.35
If JBH meets the Macquarie target it will return approximately 31% (excluding dividends, fees and charges).
Current consensus price target is $78.93, suggesting upside of 10.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Macquarie forecasts a full year FY27 dividend of 325.00 cents and EPS of 432.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 433.5, implying annual growth of N/A. Current consensus DPS estimate is 334.6, implying a prospective dividend yield of 4.7%. Current consensus EPS estimate suggests the PER is 16.5. |
Forecast for FY28:
Macquarie forecasts a full year FY28 dividend of 341.00 cents and EPS of 454.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 459.5, implying annual growth of 6.0%. Current consensus DPS estimate is 338.6, implying a prospective dividend yield of 4.7%. Current consensus EPS estimate suggests the PER is 15.6. |
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Morgan Stanley rates JBH as Underweight (5) -
Morgan Stanley maintains an Underweight rating and a Cautious industry view for JB Hi-Fi with its target price of $66.50 following an FY26 result featuring soft trading updates across core brands.
Underlying EBIT reached $734.4m, meeting consensus expectations, while net profit after tax rose 2.9% to $489.9m.
The analyst notes that July trading conditions showed negative comparable sales growth, with JB Hi-Fi Australia declining -1.4% and The Good Guys falling -1.7% due to rising supplier prices and tighter consumer wallets.
The broker's estimates project modest consensus earnings revisions lower over the next twelve months alongside margin pressure in consumer electronics.
Management highlights ongoing retail uncertainties, focusing market attention on gross margin sustainability and inventory management through upcoming promotional periods.
Target price is $66.50 Current Price is $71.65 Difference: minus $5.15 (current price is over target).
If JBH meets the Morgan Stanley target it will return approximately minus 7% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $78.93, suggesting upside of 10.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Morgan Stanley forecasts a full year FY27 dividend of 350.00 cents and EPS of 437.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 433.5, implying annual growth of N/A. Current consensus DPS estimate is 334.6, implying a prospective dividend yield of 4.7%. Current consensus EPS estimate suggests the PER is 16.5. |
Forecast for FY28:
Morgan Stanley forecasts a full year FY28 dividend of 350.00 cents and EPS of 460.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 459.5, implying annual growth of 6.0%. Current consensus DPS estimate is 338.6, implying a prospective dividend yield of 4.7%. Current consensus EPS estimate suggests the PER is 15.6. |
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Morgans rates JBH as Accumulate (2) -
JB Hi-Fi's FY26 result was broadly in line with Morgans' forecasts though sales momentum weakened in the fourth quarter and July trading disappointed.
Commentary highlights July like-for-like sales were negative across three of four divisions, reflecting stock shortages, price increases, a softer consumer backdrop and strong prior-year comparables.
The broker expects stock availability and sales momentum to improve from the second quarter, while disciplined cost management should support margins.
Morgans lowers FY27-FY28 profit forecasts by around -5% due to slower sales growth and operating deleverage. Accumulate rating retained and target falls to $82.00 from $82.90.
The broker remains positive on JB Hi-Fi's market position and replacement cycle opportunities.
Target price is $82.00 Current Price is $71.65 Difference: $10.35
If JBH meets the Morgans target it will return approximately 14% (excluding dividends, fees and charges).
Current consensus price target is $78.93, suggesting upside of 10.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Morgans forecasts a full year FY27 dividend of 337.00 cents and EPS of 449.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 433.5, implying annual growth of N/A. Current consensus DPS estimate is 334.6, implying a prospective dividend yield of 4.7%. Current consensus EPS estimate suggests the PER is 16.5. |
Forecast for FY28:
Morgans forecasts a full year FY28 dividend of 351.00 cents and EPS of 468.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 459.5, implying annual growth of 6.0%. Current consensus DPS estimate is 338.6, implying a prospective dividend yield of 4.7%. Current consensus EPS estimate suggests the PER is 15.6. |
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Ord Minnett rates JBH as Hold (3) -
JB Hi-Fi announced record FY26 sales, up 4.8% year on year. Profit rose 6.0%, and both were less than -1% below consensus, Ord Minnett notes.
The result revealed a significant slowdown in sales momentum in the fourth quarter, with comparable sales at JB Hi-Fi Australia of just 0.8% in the quarter, and flat comparable sales at The Good Guys. The deterioration has continued into July.
Management noted that customers are increasingly looking for value, and that trading was erratic.
While JB Hi-Fi is a high-quality retailer, it is also significantly exposed to discretionary spending, Ord Minnett notes, which is likely to slow further due to cost-of-living pressures, softening housing activity, and poor consumer sentiment.
Target falls to $80 from $90, Hold retained.
Target price is $80.00 Current Price is $71.65 Difference: $8.35
If JBH meets the Ord Minnett target it will return approximately 12% (excluding dividends, fees and charges).
Current consensus price target is $78.93, suggesting upside of 10.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Ord Minnett forecasts a full year FY27 dividend of 326.00 cents and EPS of 432.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 433.5, implying annual growth of N/A. Current consensus DPS estimate is 334.6, implying a prospective dividend yield of 4.7%. Current consensus EPS estimate suggests the PER is 16.5. |
Forecast for FY28:
Ord Minnett forecasts a full year FY28 dividend of 342.00 cents and EPS of 454.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 459.5, implying annual growth of 6.0%. Current consensus DPS estimate is 338.6, implying a prospective dividend yield of 4.7%. Current consensus EPS estimate suggests the PER is 15.6. |
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
UBS rates JBH as Neutral (3) -
On further inspection, EPS forecasts are lowered by -3% for FY27 and -5% for FY28 due to the challenging macro outlook which is impacting on home appliances.
Target price falls to $72 from $83 with a Neutral rating retained.
First Take: JB Hi-Fi's FY26 NPAT was broadly in line with consensus and 2% ahead of UBS, with EBIT up 3.8% to $734.4m.
The Good Guys led the earnings beat, while JB Hi-Fi Australia sales rose 4.4% and NZ remained strong with sales up 26%.
July trading softened, with like-for-like sales down -1.4% at JB Hi-Fi Australia and -1.7% at The Good Guys, both below 1H27 consensus expectations.
UBS flags margin risks from rising costs and operating deleveraging, while operating cash flow of $701m was below the broker's $805m forecast.
Neutral. Target $83.
Target price is $72.00 Current Price is $71.65 Difference: $0.35
If JBH meets the UBS target it will return approximately 0% (excluding dividends, fees and charges).
Current consensus price target is $78.93, suggesting upside of 10.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
UBS forecasts a full year FY27 dividend of 338.00 cents and EPS of 428.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 433.5, implying annual growth of N/A. Current consensus DPS estimate is 334.6, implying a prospective dividend yield of 4.7%. Current consensus EPS estimate suggests the PER is 16.5. |
Forecast for FY28:
UBS forecasts a full year FY28 dividend of 344.00 cents and EPS of 459.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 459.5, implying annual growth of 6.0%. Current consensus DPS estimate is 338.6, implying a prospective dividend yield of 4.7%. Current consensus EPS estimate suggests the PER is 15.6. |
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Macquarie rates L1G as Outperform (1) -
L1 Group's FY26 earnings were 8% ahead of consensus, reflecting stronger affiliate income, performance fees and lower costs, somewhat offset by lower base fees, Macquarie notes.
The planned cost-out was upgraded to -$43m (previously -$35m), although this is to be reinvested in new affiliates and offshore distribution teams.
Given L1's robust fund performance and significant fund capacity, Macquarie anticipates net inflows should accelerate from here. Balance sheet optionality will also support L1 in pursuing growth opportunities including acquisitions and seeding new funds.
Target rises to $1.30 from $1.25, Outperform retained.
Target price is $1.30 Current Price is $1.19 Difference: $0.115
If L1G meets the Macquarie target it will return approximately 10% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY27:
Macquarie forecasts a full year FY27 dividend of 3.50 cents and EPS of 5.80 cents. |
Forecast for FY28:
Macquarie forecasts a full year FY28 dividend of 4.20 cents and EPS of 7.00 cents. |
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
UBS rates L1G as Neutral (3) -
On further inspection, the target lifts to $1.30 from $1.25 and the Neutral rating is retained.
UBS acknowledges the upside risk from more joint venture strategies and M&A with a strong balance sheet including $634m in cash, but at current levels, the analyst does not find the valuation appealing.
First Take: L1 Group's FY26 underlying EBITDA excluding realised gains was around 2% ahead of UBS expectations, with operational revenue broadly in line.
Performance fees were strong, while management fees benefited from higher average FUM, partly offset by slightly lower fee margins.
The analyst sees potential for modest FY27 earnings downgrades as fee margins soften and operating cost guidance remains around $95m, despite upgraded cost synergies.
Upside from the launch of PXC Advisors and a new Small Cap strategy is also flagged, while L1 strategies continue to record net inflows.
The balance sheet remains strong with $635m in cash and seed investments.
Neutral. Target $1.25.
Target price is $1.30 Current Price is $1.19 Difference: $0.115
If L1G meets the UBS target it will return approximately 10% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY27:
UBS forecasts a full year FY27 dividend of 3.00 cents and EPS of 6.00 cents. |
Forecast for FY28:
UBS forecasts a full year FY28 dividend of 3.00 cents and EPS of 7.00 cents. |
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $2.87
Macquarie rates LLC as Outperform (1) -
Lendlease Group's FY26 IDC earnings landed at the upper end of guidance. FY27 guidance is for IDC earnings up 16% year on year at the midpoint, driven by Development completions and ongoing Construction growth.
However in the broker's view, investor focus will remain squarely on the pace of capital recycling and the company's ability to translate that and improving operational performance into lower gearing and improved shareholder returns.
Lendlease's strategy is expected to reduce its risk profile and improve returns and earnings quality and visibility. However, progress is taking longer than expected, Macquarie notes.
Target falls to $4.42 from $4.61, Outperform retained.
Target price is $4.42 Current Price is $2.87 Difference: $1.55
If LLC meets the Macquarie target it will return approximately 54% (excluding dividends, fees and charges).
Current consensus price target is $3.83, suggesting upside of 36.9% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Macquarie forecasts a full year FY27 dividend of 16.60 cents and EPS of 26.90 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 22.9, implying annual growth of N/A. Current consensus DPS estimate is 13.0, implying a prospective dividend yield of 4.6%. Current consensus EPS estimate suggests the PER is 12.2. |
Forecast for FY28:
Macquarie forecasts a full year FY28 dividend of 25.60 cents and EPS of 63.90 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 35.2, implying annual growth of 53.7%. Current consensus DPS estimate is 14.4, implying a prospective dividend yield of 5.1%. Current consensus EPS estimate suggests the PER is 8.0. |
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Morgan Stanley rates LLC as Equal-weight (3) -
Morgan Stanley retains an Equal-weight rating and an In-Line industry view for Lendlease Group with its target price decreased to $3.21 from $3.29 following an FY26 operating loss of -$567m.
The analyst highlights that solid performance within the investments, development, and construction segments was entirely offset by an -$800m loss in the Capital Release Unit.
The broker's estimates adjust FY27 and FY28 earnings per share down to 18.8c and 6.5c respectively, reflecting higher restructuring corporate costs, lower transaction profits, and project completion timing shifts.
Commentary explains management is navigating a simplification strategy aimed at divesting offshore assets and reducing gearing towards a target range of 5%-15%.
The analyst views the stock path as volatile over the next two to three years, while execution risks and capital recycling progress remain critical focus areas.
Target price is $3.21 Current Price is $2.87 Difference: $0.34
If LLC meets the Morgan Stanley target it will return approximately 12% (excluding dividends, fees and charges).
Current consensus price target is $3.83, suggesting upside of 36.9% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Morgan Stanley forecasts a full year FY27 dividend of 9.40 cents and EPS of 18.80 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 22.9, implying annual growth of N/A. Current consensus DPS estimate is 13.0, implying a prospective dividend yield of 4.6%. Current consensus EPS estimate suggests the PER is 12.2. |
Forecast for FY28:
Morgan Stanley forecasts a full year FY28 dividend of 3.20 cents and EPS of 6.50 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 35.2, implying annual growth of 53.7%. Current consensus DPS estimate is 14.4, implying a prospective dividend yield of 5.1%. Current consensus EPS estimate suggests the PER is 8.0. |
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $39.46
Citi rates NAB as Neutral (3) -
Citi remains Neutral rated with a higher target of $40 from $28, noting ANZ Bank ((ANZ)) remains the preferred bank and then National Australia Bank.
The broker remains more positive on banks with greater business lending exposure following a mixed June quarter reporting season for the majors.
Core earnings rose around 4% q/q, although investor reactions varied considerably, with ANZ standing out positively.
Into FY27, strong business credit demand is expected to contrast with increasing pressure on retail banking from softer mortgage volumes, deposit mix, competition and pricing, weighing on NIMs. The broker sees fewer avenues for revenue growth as these pressures build.
On first glance, Citi notes National Australia Bank reported cash earnings -2% below consensus. Relative to consensus, the miss was largely attributable to lower markets & trading income, which Citi estimates was down -10% in the quarter, indicative of the quarterly volatility.
Costs were slightly higher as a function of accounting policy changes, but management maintained FY26 guidance of more than 4.6% cost growth. Bad debts were in line with expectations, and non-performing loans declined by -2bps in the quarter, slightly better than peers.
Overall, despite the small profit miss, given it is markets & trading related, Citi thinks today's market update gets looked through. Neutral and $38 target retained.
Target price is $40.00 Current Price is $39.46 Difference: $0.54
If NAB meets the Citi target it will return approximately 1% (excluding dividends, fees and charges).
Current consensus price target is $39.02, suggesting downside of -0.8% (ex-dividends)
The company's fiscal year ends in September.
Forecast for FY26:
Citi forecasts a full year FY26 dividend of 170.00 cents and EPS of 206.20 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 210.9, implying annual growth of -4.6%. Current consensus DPS estimate is 170.0, implying a prospective dividend yield of 4.3%. Current consensus EPS estimate suggests the PER is 18.7. |
Forecast for FY27:
Citi forecasts a full year FY27 dividend of 170.00 cents and EPS of 252.40 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 244.2, implying annual growth of 15.8%. Current consensus DPS estimate is 170.0, implying a prospective dividend yield of 4.3%. Current consensus EPS estimate suggests the PER is 16.1. |
Market Sentiment: -0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Macquarie rates NAB as Neutral (3) -
National Australia Bank delivered a softer June Q update, Macquarie notes, with weaker markets income contributing to a -2% pre-provision earnings miss. Rising competition and fading replicating portfolio tailwinds in the Sep Q are likely to result in 2H26 consensus margin downgrades.
NAB’s non-performing loans remain above peers, but stability during the quarter was encouraging, Macquarie suggests. NAB expects mortgage credit growth to slow to 2.5% in FY27, -1% below Macquarie and more cautious than its major bank peers.
NAB continues to deliver balance sheet growth across priority segments, with lower execution risk given the absence of a significant transformation agenda. Slowing revenue, rising competition and broader macro concerns leave limited scope for near-term upside, in the broker's view.
Neutral and $39 target retained.
Target price is $39.00 Current Price is $39.46 Difference: minus $0.46 (current price is over target).
If NAB meets the Macquarie target it will return approximately minus 1% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $39.02, suggesting downside of -0.8% (ex-dividends)
The company's fiscal year ends in September.
Forecast for FY26:
Macquarie forecasts a full year FY26 dividend of 170.00 cents and EPS of 207.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 210.9, implying annual growth of -4.6%. Current consensus DPS estimate is 170.0, implying a prospective dividend yield of 4.3%. Current consensus EPS estimate suggests the PER is 18.7. |
Forecast for FY27:
Macquarie forecasts a full year FY27 dividend of 170.00 cents and EPS of 240.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 244.2, implying annual growth of 15.8%. Current consensus DPS estimate is 170.0, implying a prospective dividend yield of 4.3%. Current consensus EPS estimate suggests the PER is 16.1. |
Market Sentiment: -0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Morgan Stanley rates NAB as Underweight (5) -
Morgan Stanley maintains an Underweight rating and a Cautious industry view for National Australia Bank with a $34.00 target price, citing an uncertain operating environment and weak earnings outlook that make recent share price rallies hard to justify.
Operating trends remain sound, but revenue growth is slowing alongside limited flexibility on costs and capital.
Individual provisions reached their lowest level since 1Q25, yet underlying credit quality appears to be turning amid a deteriorating Australian economic outlook, Morgan Stanley observes.
The broker lowers forecast FY27 cash EPS by -1.5%, projecting a modest EPS decline and an ROE of 10.8%.
Management commentary indicates dividend growth may lag earnings progress, leaving limited capital flexibility across the forecast period.
Target price is $34.00 Current Price is $39.46 Difference: minus $5.46 (current price is over target).
If NAB meets the Morgan Stanley target it will return approximately minus 14% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $39.02, suggesting downside of -0.8% (ex-dividends)
The company's fiscal year ends in September.
Forecast for FY26:
Morgan Stanley forecasts a full year FY26 dividend of 170.00 cents and EPS of 204.30 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 210.9, implying annual growth of -4.6%. Current consensus DPS estimate is 170.0, implying a prospective dividend yield of 4.3%. Current consensus EPS estimate suggests the PER is 18.7. |
Forecast for FY27:
Morgan Stanley forecasts a full year FY27 dividend of 170.00 cents and EPS of 229.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 244.2, implying annual growth of 15.8%. Current consensus DPS estimate is 170.0, implying a prospective dividend yield of 4.3%. Current consensus EPS estimate suggests the PER is 16.1. |
Market Sentiment: -0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Ord Minnett rates NAB as Hold (3) -
National Australia Bank's third quarter trading update showed revenues increased 2% on the quarterly average in the first half and underlying cash profit rose 1.8%.
Net interest margin (NIM) decreased by -2 basis points (bp) to 1.79% on the 1H26 quarterly average, albeit excluding markets and treasury income, NIM was up 2bps, Ord Minnett notes.
Operating expenses rose 4% on rising technology costs. Asset quality trends, on balance, look slightly weaker. Business lending was relatively strong, the broker suggests, up approximately 2% on the March quarter, but home lending growth was just 1%.
The CET1 capital ratio strengthened to 11.9% from 11.7% in the March quarter but it is the weakest of the major Australian banks.
As Australia's largest business bank, NAB is well-placed to deliver strong growth in the medium term given better momentum in business lending, commentary posits, but larger exposure to small–medium enterprises may be a drawback should there be a more significant deterioration in the economy.
On that basis, Ord Minnett retains Hold, with an unchanged $37 target.
Target price is $37.00 Current Price is $39.46 Difference: minus $2.46 (current price is over target).
If NAB meets the Ord Minnett target it will return approximately minus 6% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $39.02, suggesting downside of -0.8% (ex-dividends)
The company's fiscal year ends in September.
Forecast for FY26:
Ord Minnett forecasts a full year FY26 dividend of 170.00 cents and EPS of 207.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 210.9, implying annual growth of -4.6%. Current consensus DPS estimate is 170.0, implying a prospective dividend yield of 4.3%. Current consensus EPS estimate suggests the PER is 18.7. |
Forecast for FY27:
Ord Minnett forecasts a full year FY27 dividend of 170.00 cents and EPS of 246.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 244.2, implying annual growth of 15.8%. Current consensus DPS estimate is 170.0, implying a prospective dividend yield of 4.3%. Current consensus EPS estimate suggests the PER is 16.1. |
Market Sentiment: -0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
UBS rates NAB as Buy (1) -
On further inspection, the EPS forecasts are trimmed by -2.3% for FY26 and -3.8% for FY27. The lower EPS forecasts result in a lower DPS forecast for FY27, down -2.5%, to remain flat on FY26 expectations.
Buy rating retained.
Target price is lowered to $48 from $50.
First Take: National Australia Bank's 3Q26 cash earnings were slightly below expectations, with UBS attributing the miss to slower NII growth, partly offset by better costs and lower credit impairment charges.
Unaudited cash earnings of $1.83bn were up 3% y/y, while NIM fell -2bps to 179bps, despite core NIM improving 2bps.
The analyst notes asset quality remains stable, with the -$299m credit impairment charge falling from -$536m in 2Q26, while CET1 improved 28bps to 11.93%.
Business lending rose 2.12% QoQ and deposits increased 1.77%, although housing lending growth slowed to 1.29% and applications have fallen -15% since 2Q26.
Management reaffirmed FY26 guidance for more than $450m of productivity savings and operating expense growth below 4.6%.
Buy. Target $50.
Target price is $48.00 Current Price is $39.46 Difference: $8.54
If NAB meets the UBS target it will return approximately 22% (excluding dividends, fees and charges).
Current consensus price target is $39.02, suggesting downside of -0.8% (ex-dividends)
The company's fiscal year ends in September.
Forecast for FY26:
UBS forecasts a full year FY26 dividend of 170.00 cents and EPS of 233.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 210.9, implying annual growth of -4.6%. Current consensus DPS estimate is 170.0, implying a prospective dividend yield of 4.3%. Current consensus EPS estimate suggests the PER is 18.7. |
Forecast for FY27:
UBS forecasts a full year FY27 dividend of 170.00 cents and EPS of 241.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 244.2, implying annual growth of 15.8%. Current consensus DPS estimate is 170.0, implying a prospective dividend yield of 4.3%. Current consensus EPS estimate suggests the PER is 16.1. |
Market Sentiment: -0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $5.61
Bell Potter rates NHC as Hold (3) -
Bell Potter maintains a Hold rating for New Hope with a $5.00 target price following the release of a solid quarterly update.
The analyst highlights strong production performance and disciplined cost management across the coal assets, enabling robust free cash generation despite softer global energy pricing backdrops.
The broker's estimates adjust near-term earnings forecasts to reflect prevailing commodity price realisations and ongoing operational optimisation.
Management continues to prioritise shareholder returns alongside disciplined capital allocation for growth projects like New Acland.
The analyst views the share price as fully valued at current levels, noting that a balanced risk-reward profile supports maintaining a neutral stance.
Target price is $5.00 Current Price is $5.61 Difference: minus $0.61 (current price is over target).
If NHC meets the Bell Potter target it will return approximately minus 11% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $5.46, suggesting downside of -3.8% (ex-dividends)
The company's fiscal year ends in July.
Forecast for FY26:
Bell Potter forecasts a full year FY26 dividend of 20.00 cents and EPS of 18.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 17.9, implying annual growth of -65.6%. Current consensus DPS estimate is 24.3, implying a prospective dividend yield of 4.3%. Current consensus EPS estimate suggests the PER is 31.7. |
Forecast for FY27:
Bell Potter forecasts a full year FY27 dividend of 30.00 cents and EPS of 42.10 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 37.5, implying annual growth of 109.5%. Current consensus DPS estimate is 29.0, implying a prospective dividend yield of 5.1%. Current consensus EPS estimate suggests the PER is 15.1. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Macquarie rates NHC as Outperform (1) -
New Hope's July Q production beat by 4% and in-line sales by 2%, with earnings in-line due to lower costs on weaker realised pricing. Bengalla production beat, while New Ackland fell short on planned shutdowns and Queensland rail disruptions.
Strong free cash flow generation sees FY26 closing cash of $0.8bn, with potential for capital returns given a "significant" franking credit balance, Macquarie notes.
Target rises to $6.40 from $6.20, Outperform retained.
Target price is $6.40 Current Price is $5.61 Difference: $0.79
If NHC meets the Macquarie target it will return approximately 14% (excluding dividends, fees and charges).
Current consensus price target is $5.46, suggesting downside of -3.8% (ex-dividends)
The company's fiscal year ends in July.
Forecast for FY26:
Macquarie forecasts a full year FY26 dividend of 23.00 cents and EPS of 16.80 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 17.9, implying annual growth of -65.6%. Current consensus DPS estimate is 24.3, implying a prospective dividend yield of 4.3%. Current consensus EPS estimate suggests the PER is 31.7. |
Forecast for FY27:
Macquarie forecasts a full year FY27 dividend of 17.00 cents and EPS of 33.30 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 37.5, implying annual growth of 109.5%. Current consensus DPS estimate is 29.0, implying a prospective dividend yield of 5.1%. Current consensus EPS estimate suggests the PER is 15.1. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Morgans rates NHC as Hold (3) -
Morgans views New Hope's fourth quarter positively, with stronger-than-expected cash and production supporting an improved dividend outlook. New Hope has a July year end.
FY26 production exceeded guidance, led by a strong Bengalla performance, the analyst highlights. Realised coal prices rose 11% quarter-on-quarter, lifting underlying earnings (EBITDA) 30%.
The broker expects further FY27 production growth as New Acland ramps towards nameplate capacity and Bengalla benefits from more normal weather conditions.
New Hope finished FY26 with $485m cash, materially ahead of Morgans' expectations, prompting the analyst to increase dividend assumptions for 2H26 and beyond.
Morgans raises its target by 20c to $5.45 and retains a Hold rating.
Target price is $5.45 Current Price is $5.61 Difference: minus $0.16 (current price is over target).
If NHC meets the Morgans target it will return approximately minus 3% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $5.46, suggesting downside of -3.8% (ex-dividends)
The company's fiscal year ends in July.
Forecast for FY26:
Morgans forecasts a full year FY26 dividend of 30.00 cents and EPS of 19.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 17.9, implying annual growth of -65.6%. Current consensus DPS estimate is 24.3, implying a prospective dividend yield of 4.3%. Current consensus EPS estimate suggests the PER is 31.7. |
Forecast for FY27:
Morgans forecasts a full year FY27 dividend of 40.00 cents and EPS of 37.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 37.5, implying annual growth of 109.5%. Current consensus DPS estimate is 29.0, implying a prospective dividend yield of 5.1%. Current consensus EPS estimate suggests the PER is 15.1. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
NST NORTHERN STAR RESOURCES LIMITED
Gold & Silver
More Research Tools In Stock Analysis - click HERE
Overnight Price: $23.19
Citi rates NST as Downgrade to Neutral from Buy (3) -
Citi updates its gold coverage post the June quarter results. The commodities team remains bullish on the gold price with the 6-12 months target unchanged at US$5,000/oz.
The FY27 AUD gold price forecast is lowered by around -9%, which is noted as "phasing" and not a change in the structural view.
The broker cuts FY27 EBITDA forecasts by around -20%, excluding Evolution Mining ((EVN)), which is lowered -5%. FY27 and FY28 AISC estimates rise around 4%-12%, reflecting higher diesel costs as Brent crude is up 34% YoY.
Northern Star Resources is downgraded to Neutral from Buy post the highest AISC rise of 12% and a cut in FY27 production expectations, as well as 788koz hedged at $3,397/oz which caps gold upside. Target price falls to $24.30 from $29.70.
Genesis Minerals ((GMD)) is the preferred exposure. The Vault acquisition offers upside.
Target price is $24.30 Current Price is $23.19 Difference: $1.11
If NST meets the Citi target it will return approximately 5% (excluding dividends, fees and charges).
Current consensus price target is $25.11, suggesting upside of 12.3% (ex-dividends)
Forecast for FY26:
Current consensus EPS estimate is 131.0, implying annual growth of 16.3%. Current consensus DPS estimate is 52.8, implying a prospective dividend yield of 2.4%. Current consensus EPS estimate suggests the PER is 17.1. |
Forecast for FY27:
Current consensus EPS estimate is 168.5, implying annual growth of 28.6%. Current consensus DPS estimate is 59.8, implying a prospective dividend yield of 2.7%. Current consensus EPS estimate suggests the PER is 13.3. |
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $14.78
UBS rates NXG as Buy (1) -
UBS notes NexGen Energy shares traded up 7% on reports BHP Group ((BHP)) had 'run a ruler over' the last year.
The broker highlights that BHP would bring balance sheet, sales and marketing, and shaft sinking experience.
Equally, the new CEO is expected to take a "really good look" at uranium, while doing scale is "hard".
Currently, BHP produces around 5% of global U308 from Olympic Dam by-product.
For NexGen, management aims to secure funding within around 9 months and ground-breaking celebration occurred last week.
Buy rated. Target CA$18.
Current Price is $14.78. Target price not assessed.
The company's fiscal year ends in December.
Forecast for FY26:
UBS forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 0.20 cents. |
Forecast for FY27:
UBS forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 0.14 cents. |
This company reports in CAD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $1.66
Macquarie rates OML as Neutral (3) -
oOh!media reported 1H26 profit down -42% year on year, below consensus, impacted by a -4.3 percentage point drop in the gross margin to 37.5%.
Macquarie now forecasts 2026 earnings, flat year on year, with solid second half momentum, noting July earnings were more than double year on year, and August is going to see a similar favourable operating leverage.
oOh!media entered a binding agreement to be acquired by I Squared in early-August 2026, and was unanimously approved by the board. The company has good 2H26 momentum, and should meet customary conditions for I Squared to complete the take-over, Macquarie believes.
Neutral and $1.58 target retained.
Target price is $1.58 Current Price is $1.66 Difference: minus $0.08 (current price is over target).
If OML meets the Macquarie target it will return approximately minus 5% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $1.54, suggesting downside of -7.0% (ex-dividends)
The company's fiscal year ends in December.
Forecast for FY26:
Macquarie forecasts a full year FY26 dividend of 12.00 cents and EPS of 11.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 11.3, implying annual growth of 257.6%. Current consensus DPS estimate is 8.0, implying a prospective dividend yield of 4.8%. Current consensus EPS estimate suggests the PER is 14.7. |
Forecast for FY27:
Macquarie forecasts a full year FY27 dividend of 7.00 cents and EPS of 13.70 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 13.1, implying annual growth of 15.9%. Current consensus DPS estimate is 7.0, implying a prospective dividend yield of 4.2%. Current consensus EPS estimate suggests the PER is 12.7. |
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $5.66
Citi rates PRU as Buy (1) -
Citi updates its gold coverage post the June quarter results. The commodities team remains bullish on the gold price with the 6-12 months target unchanged at US$5,000/oz.
The FY27 AUD gold price forecast is lowered by around -9%, which is noted as "phasing" and not a change in the structural view.
The broker cuts FY27 EBITDA forecasts by around -20%, excluding Evolution Mining ((EVN)), which is lowered -5%. FY27 and FY28 AISC estimates rise around 4%-12%, reflecting higher diesel costs as Brent crude is up 34% YoY.
Perseus Mining remains Buy rated (High risk) with a lower target of $6.80 from $7.
Target price is $6.80 Current Price is $5.66 Difference: $1.14
If PRU meets the Citi target it will return approximately 20% (excluding dividends, fees and charges).
Current consensus price target is $6.34, suggesting upside of 13.8% (ex-dividends)
Forecast for FY26:
Current consensus EPS estimate is 47.0, implying annual growth of N/A. Current consensus DPS estimate is 13.5, implying a prospective dividend yield of 2.4%. Current consensus EPS estimate suggests the PER is 11.9. |
Forecast for FY27:
Current consensus EPS estimate is 57.7, implying annual growth of 22.8%. Current consensus DPS estimate is 13.8, implying a prospective dividend yield of 2.5%. Current consensus EPS estimate suggests the PER is 9.7. |
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
REA REA GROUP LIMITED
Online media & mobile platforms
More Research Tools In Stock Analysis - click HERE
Overnight Price: $177.38
Morgan Stanley rates REA as Overweight (1) -
Morgan Stanley maintains an Overweight rating for REA Group with its target price increased to $230.00 from $225.00 following FY26 results that exceeded expectations and demonstrated strong cost discipline.
The analyst notes near-term listings volumes face cyclical headwinds from recent RBA rate hikes, leading to a base case forecast of a -5% decline in FY27 listings.
The broker's estimates project double-digit yield growth and ongoing artificial intelligence product innovation will drive core earnings resilience.
Long-term fundamental value is supported by consistent pricing power and expanding EBITDA margins across the Australian digital real estate platform.
The analyst considers temporary cyclical weakness an attractive entry point given historical precedents of swift volume recoveries following interest rate turning points.
Target price is $230.00 Current Price is $177.38 Difference: $52.62
If REA meets the Morgan Stanley target it will return approximately 30% (excluding dividends, fees and charges).
Current consensus price target is $190.68, suggesting upside of 6.8% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY27:
Morgan Stanley forecasts a full year FY27 dividend of 329.60 cents and EPS of 571.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 568.6, implying annual growth of 35.9%. Current consensus DPS estimate is 344.4, implying a prospective dividend yield of 1.9%. Current consensus EPS estimate suggests the PER is 31.4. |
Forecast for FY28:
Morgan Stanley forecasts a full year FY28 dividend of 380.70 cents and EPS of 655.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 641.7, implying annual growth of 12.9%. Current consensus DPS estimate is 389.7, implying a prospective dividend yield of 2.2%. Current consensus EPS estimate suggests the PER is 27.8. |
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $7.57
Citi rates RRL as Neutral (3) -
Citi updates its gold coverage post the June quarter results. The commodities team remains bullish on the gold price with the 6-12 months target unchanged at US$5,000/oz.
The FY27 AUD gold price forecast is lowered by around -9%, which is noted as "phasing" and not a change in the structural view.
The broker cuts FY27 EBITDA forecasts by around -20%, excluding Evolution Mining ((EVN)), which is lowered -5%. FY27 and FY28 AISC estimates rise around 4%-12%, reflecting higher diesel costs as Brent crude is up 34% YoY.
Regis Resources remains Neutral rated with a lower target of $7.40 from $8.10.
Target price is $7.40 Current Price is $7.57 Difference: minus $0.17 (current price is over target).
If RRL meets the Citi target it will return approximately minus 2% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $7.53, suggesting upside of 0.8% (ex-dividends)
Forecast for FY26:
Current consensus EPS estimate is 101.3, implying annual growth of 200.9%. Current consensus DPS estimate is 33.5, implying a prospective dividend yield of 4.5%. Current consensus EPS estimate suggests the PER is 7.4. |
Forecast for FY27:
Current consensus EPS estimate is 118.3, implying annual growth of 16.8%. Current consensus DPS estimate is 31.8, implying a prospective dividend yield of 4.3%. Current consensus EPS estimate suggests the PER is 6.3. |
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $0.15
Morgans rates SVL as Speculative Buy (1) -
Morgans explains the Bowdens definitive feasibility study (DFS) confirms for management at Silver Mines a materially larger, longer-life project.
Silver reserves increased 30% to 93.5Moz at 60.8g/t and the operating life extends to 26 years from 16 years.
Project economics also strengthened, the analyst suggests, with Stage 1 pre-tax net present value (NPV) rising 144% and the internal rate of return (IRR) increasing to 31.5%.
Development capex increased 37% to $455m, largely reflecting inflation and a shift to more expensive dry-stack tailings infrastructure, the broker explains.
Despite permitting remaining the key risk, Morgans sees improving project maturity and a clearer approvals pathway. The target is raised to $0.43 from $0.40. Speculative Buy rating maintained.
Target price is $0.43 Current Price is $0.15 Difference: $0.28
If SVL meets the Morgans target it will return approximately 187% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $2.21
Morgan Stanley rates TUA as Overweight (1) -
Morgan Stanley maintains an Overweight rating and an In-Line industry view for Tuas with a $5.00 target price, noting that recent M1 deal terminations materially depressed near-term sentiment while leaving strong organic growth intact.
The analyst highlights that mobile and broadband subscriber momentum continues to drive robust performance, with cash balances providing solid valuation downside protection.
Regulatory uncertainty surrounding alleged spectrum breaches creates an overhang, overshadowing operational progress.
The broker projects FY27 revenue reaching $225.5m and EBITDA expanding to $99.6m as market share gains proceed.
The analyst views current "dislocation" as an attractive entry point, supported by strong free cash flow generation and solid subscriber conversion rates.
Target price is $5.00 Current Price is $2.21 Difference: $2.79
If TUA meets the Morgan Stanley target it will return approximately 126% (excluding dividends, fees and charges).
The company's fiscal year ends in July.
Forecast for FY26:
Morgan Stanley forecasts a full year FY26 dividend of 0.00 cents and EPS of 3.05 cents. |
Forecast for FY27:
Morgan Stanley forecasts a full year FY27 dividend of 0.00 cents and EPS of 6.19 cents. |
This company reports in SGD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $35.07
Citi rates WBC as Neutral (3) -
Citi remains more positive on banks with greater business lending exposure following a mixed June quarter reporting season for the majors.
Core earnings rose around 4% QoQ, although investor reactions varied considerably, with ANZ Bank ((ANZ)) standing out positively.
Looking into FY27, strong business credit demand is expected to contrast with increasing pressure on retail banking from softer mortgage volumes, deposit mix, competition and pricing, weighing on NIMs.
The broker sees fewer avenues for revenue growth as these pressures build.
Westpac remains Neutral rated with a lower target of $35.50, down from $37.
Target price is $35.50 Current Price is $35.07 Difference: $0.43
If WBC meets the Citi target it will return approximately 1% (excluding dividends, fees and charges).
Current consensus price target is $33.86, suggesting downside of -2.3% (ex-dividends)
The company's fiscal year ends in September.
Forecast for FY26:
Citi forecasts a full year FY26 dividend of 155.00 cents and EPS of 205.60 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 203.6, implying annual growth of 0.8%. Current consensus DPS estimate is 155.4, implying a prospective dividend yield of 4.5%. Current consensus EPS estimate suggests the PER is 17.0. |
Forecast for FY27:
Citi forecasts a full year FY27 dividend of 160.00 cents and EPS of 208.50 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 211.1, implying annual growth of 3.7%. Current consensus DPS estimate is 162.0, implying a prospective dividend yield of 4.7%. Current consensus EPS estimate suggests the PER is 16.4. |
Market Sentiment: -0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Today's Price Target Changes
| Company | Last Price | Broker | New Target | Prev Target | Change | |
| A2M | a2 Milk Co | $7.09 | Bell Potter | 7.00 | 6.90 | 1.45% |
| Citi | 7.40 | 7.00 | 5.71% | |||
| Macquarie | 8.10 | 8.50 | -4.71% | |||
| Morgans | 7.62 | 8.30 | -8.19% | |||
| ACL | Australian Clinical Labs | $2.83 | Macquarie | 2.70 | 2.30 | 17.39% |
| Ord Minnett | 2.60 | 2.20 | 18.18% | |||
| AD8 | Audinate Group | $2.45 | Macquarie | 4.80 | 3.20 | 50.00% |
| UBS | 5.25 | 6.10 | -13.93% | |||
| ALL | Aristocrat Leisure | $63.60 | Morgans | 70.00 | 67.00 | 4.48% |
| AZJ | Aurizon Holdings | $3.63 | Citi | 3.90 | 4.00 | -2.50% |
| Macquarie | 3.84 | 4.09 | -6.11% | |||
| Morgans | 3.56 | 3.55 | 0.28% | |||
| Ord Minnett | 3.40 | N/A | - | |||
| UBS | 3.40 | 3.50 | -2.86% | |||
| BSL | BlueScope Steel | $31.50 | Morgan Stanley | 34.00 | 32.35 | 5.10% |
| Ord Minnett | 29.00 | 27.50 | 5.45% | |||
| DOC | Doctor Care Anywhere | $0.12 | Bell Potter | 0.22 | 0.24 | -8.33% |
| EDV | Endeavour Group | $3.43 | Bell Potter | 3.60 | 3.85 | -6.49% |
| EVN | Evolution Mining | $13.53 | Citi | 13.70 | 15.00 | -8.67% |
| FRW | Freightways Group | $11.91 | Ord Minnett | 13.20 | 13.87 | -4.83% |
| GGP | Greatland Resources | $12.41 | Citi | 14.00 | 16.00 | -12.50% |
| GMD | Genesis Minerals | $7.33 | Citi | 8.60 | 10.00 | -14.00% |
| GOZ | Growthpoint Properties Australia | $2.13 | Macquarie | 2.30 | 2.47 | -6.88% |
| GPT | GPT Group | $4.80 | Macquarie | 5.10 | 5.37 | -5.03% |
| Ord Minnett | 5.15 | 5.30 | -2.83% | |||
| GWA | GWA Group | $2.26 | Macquarie | 2.30 | 2.15 | 6.98% |
| IMD | Imdex | $3.77 | Bell Potter | 4.00 | 4.60 | -13.04% |
| Macquarie | 5.00 | 4.60 | 8.70% | |||
| Morgans | 4.30 | 5.00 | -14.00% | |||
| UBS | 5.05 | 5.15 | -1.94% | |||
| IRE | Iress | $6.40 | Macquarie | 7.72 | 7.65 | 0.92% |
| Morgans | 9.65 | 10.35 | -6.76% | |||
| JBH | JB Hi-Fi | $71.72 | Bell Potter | 81.00 | 87.00 | -6.90% |
| Citi | 77.00 | 85.00 | -9.41% | |||
| Macquarie | 94.00 | 98.00 | -4.08% | |||
| Morgans | 82.00 | 82.90 | -1.09% | |||
| Ord Minnett | 80.00 | 90.00 | -11.11% | |||
| UBS | 72.00 | 83.00 | -13.25% | |||
| L1G | L1 Group | $1.21 | Macquarie | 1.30 | 1.25 | 4.00% |
| UBS | 1.30 | 1.25 | 4.00% | |||
| LLC | Lendlease Group | $2.80 | Macquarie | 4.42 | 4.61 | -4.12% |
| Morgan Stanley | 3.21 | 3.29 | -2.43% | |||
| NAB | National Australia Bank | $39.35 | Citi | 40.00 | 38.00 | 5.26% |
| UBS | 48.00 | 50.00 | -4.00% | |||
| NHC | New Hope | $5.68 | Macquarie | 6.40 | 6.20 | 3.23% |
| Morgans | 5.45 | 5.25 | 3.81% | |||
| NST | Northern Star Resources | $22.36 | Citi | 24.30 | 29.70 | -18.18% |
| NXG | NexGen Energy | $15.26 | UBS | N/A | 18.50 | -100.00% |
| OML | oOh!media | $1.66 | Macquarie | 1.58 | N/A | - |
| PRU | Perseus Mining | $5.57 | Citi | 6.80 | 7.00 | -2.86% |
| REA | REA Group | $178.62 | Morgan Stanley | 230.00 | 225.00 | 2.22% |
| RRL | Regis Resources | $7.47 | Citi | 7.40 | 8.10 | -8.64% |
| SVL | Silver Mines | $0.15 | Morgans | 0.43 | 0.40 | 7.50% |
| WBC | Westpac | $34.66 | Citi | 35.50 | 37.00 | -4.05% |
Summaries
| A2M | a2 Milk Co | Hold - Bell Potter | Overnight Price $6.53 |
| Upgrade to Buy from Neutral - Citi | Overnight Price $6.53 | ||
| Outperform - Macquarie | Overnight Price $6.53 | ||
| Accumulate - Morgans | Overnight Price $6.53 | ||
| Buy - Ord Minnett | Overnight Price $6.53 | ||
| Buy - UBS | Overnight Price $6.53 | ||
| ACL | Australian Clinical Labs | Neutral - Macquarie | Overnight Price $2.70 |
| Hold - Ord Minnett | Overnight Price $2.70 | ||
| AD8 | Audinate Group | Upgrade to Outperform from Neutral - Macquarie | Overnight Price $2.33 |
| Upgrade to Overweight from Equal-weight - Morgan Stanley | Overnight Price $2.33 | ||
| Buy - UBS | Overnight Price $2.33 | ||
| ALL | Aristocrat Leisure | Downgrade to Accumulate from Buy - Morgans | Overnight Price $64.50 |
| ANZ | ANZ Bank | Buy - Citi | Overnight Price $37.88 |
| AZJ | Aurizon Holdings | Neutral - Citi | Overnight Price $3.73 |
| Neutral - Macquarie | Overnight Price $3.73 | ||
| Upgrade to Hold from Trim - Morgans | Overnight Price $3.73 | ||
| Hold - Ord Minnett | Overnight Price $3.73 | ||
| Sell - UBS | Overnight Price $3.73 | ||
| BHP | BHP Group | Neutral - Macquarie | Overnight Price $62.20 |
| BSL | BlueScope Steel | Equal-weight - Morgan Stanley | Overnight Price $32.94 |
| Downgrade to Lighten from Hold - Ord Minnett | Overnight Price $32.94 | ||
| COH | Cochlear | Neutral - UBS | Overnight Price $131.25 |
| CSL | CSL | Neutral - Macquarie | Overnight Price $134.60 |
| Buy - UBS | Overnight Price $134.60 | ||
| CUP | Count | Initiation of coverage with Buy - Ord Minnett | Overnight Price $1.35 |
| DOC | Doctor Care Anywhere | Buy - Bell Potter | Overnight Price $0.12 |
| EDV | Endeavour Group | Downgrade to Hold from Buy - Bell Potter | Overnight Price $3.52 |
| EVN | Evolution Mining | Neutral - Citi | Overnight Price $13.89 |
| FDC | FDC Consolidated | Initiation of coverage with Accumulate - Morgans | Overnight Price $3.70 |
| FRW | Freightways Group | Outperform - Macquarie | Overnight Price $11.91 |
| Downgrade to Accumulate from Buy - Ord Minnett | Overnight Price $11.91 | ||
| Neutral - UBS | Overnight Price $11.91 | ||
| GGP | Greatland Resources | Buy - Citi | Overnight Price $12.44 |
| GMD | Genesis Minerals | Buy - Citi | Overnight Price $7.50 |
| GOZ | Growthpoint Properties Australia | Buy - Citi | Overnight Price $2.16 |
| Outperform - Macquarie | Overnight Price $2.16 | ||
| GPT | GPT Group | Buy - Citi | Overnight Price $5.00 |
| Downgrade to Neutral from Outperform - Macquarie | Overnight Price $5.00 | ||
| Accumulate - Ord Minnett | Overnight Price $5.00 | ||
| Buy - UBS | Overnight Price $5.00 | ||
| GWA | GWA Group | Neutral - Macquarie | Overnight Price $2.40 |
| IMD | Imdex | Downgrade to Hold from Buy - Bell Potter | Overnight Price $3.69 |
| Outperform - Macquarie | Overnight Price $3.69 | ||
| Downgrade to Accumulate from Buy - Morgans | Overnight Price $3.69 | ||
| Buy - UBS | Overnight Price $3.69 | ||
| IRE | Iress | Outperform - Macquarie | Overnight Price $6.99 |
| Buy - Morgans | Overnight Price $6.99 | ||
| JBH | JB Hi-Fi | Buy - Bell Potter | Overnight Price $71.65 |
| Neutral - Citi | Overnight Price $71.65 | ||
| Outperform - Macquarie | Overnight Price $71.65 | ||
| Underweight - Morgan Stanley | Overnight Price $71.65 | ||
| Accumulate - Morgans | Overnight Price $71.65 | ||
| Hold - Ord Minnett | Overnight Price $71.65 | ||
| Neutral - UBS | Overnight Price $71.65 | ||
| L1G | L1 Group | Outperform - Macquarie | Overnight Price $1.19 |
| Neutral - UBS | Overnight Price $1.19 | ||
| LLC | Lendlease Group | Outperform - Macquarie | Overnight Price $2.87 |
| Equal-weight - Morgan Stanley | Overnight Price $2.87 | ||
| NAB | National Australia Bank | Neutral - Citi | Overnight Price $39.46 |
| Neutral - Macquarie | Overnight Price $39.46 | ||
| Underweight - Morgan Stanley | Overnight Price $39.46 | ||
| Hold - Ord Minnett | Overnight Price $39.46 | ||
| Buy - UBS | Overnight Price $39.46 | ||
| NHC | New Hope | Hold - Bell Potter | Overnight Price $5.61 |
| Outperform - Macquarie | Overnight Price $5.61 | ||
| Hold - Morgans | Overnight Price $5.61 | ||
| NST | Northern Star Resources | Downgrade to Neutral from Buy - Citi | Overnight Price $23.19 |
| NXG | NexGen Energy | Buy - UBS | Overnight Price $14.78 |
| OML | oOh!media | Neutral - Macquarie | Overnight Price $1.66 |
| PRU | Perseus Mining | Buy - Citi | Overnight Price $5.66 |
| REA | REA Group | Overweight - Morgan Stanley | Overnight Price $177.38 |
| RRL | Regis Resources | Neutral - Citi | Overnight Price $7.57 |
| SVL | Silver Mines | Speculative Buy - Morgans | Overnight Price $0.15 |
| TUA | Tuas | Overweight - Morgan Stanley | Overnight Price $2.21 |
| WBC | Westpac | Neutral - Citi | Overnight Price $35.07 |
RATING SUMMARY
| Rating | No. Of Recommendations |
| 1. Buy | 34 |
| 2. Accumulate | 7 |
| 3. Hold | 30 |
| 4. Reduce | 1 |
| 5. Sell | 3 |
Tuesday 18 August 2026
Access Broker Call Report Archives here
Disclaimer:
The content of this information does in no way reflect the opinions of
FNArena, or of its journalists. In fact we don't have any opinion about
the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe
and comment on. By doing so we believe we provide intelligent investors
with a valuable tool that helps them in making up their own minds, reading
market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not
constitute an offer to sell or a solicitation to buy any security or other
financial instrument. FNArena employs very experienced journalists who
base their work on information believed to be reliable and accurate, though
no guarantee is given that the daily report is accurate or complete. Investors
should contact their personal adviser before making any investment decision.
Latest News
| 1 |
The Market In Numbers – 21 Nov 2026Nov 21 2026 - Australia |
| 2 |
ASX Winners And Losers Of Today – 20-11-26Nov 20 2026 - Daily Market Reports |
| 3 |
FNArena Corporate Results Monitor – 20-11-2026Nov 20 2026 - Australia |
| 4 |
Next Week At A Glance – 23-27 Nov 2026Nov 20 2026 - Weekly Reports |
| 5 |
Weekly Top Ten News Stories – 20 November 2026Nov 20 2026 - Weekly Reports |

